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Generation and Characterization of an Attenuated Mutant in a Response-Regulator
Gene of Francisella Tularensis Live Vaccine Strain (LVS)
Wendy L. Sammons
ABSTRACT

Francisella tularensis is a zoonotic bacterium that must exist in diverse
environments ranging from arthropod vectors to mammalian hosts. To better understand
how genes are regulated in these different environments, a transcriptional responseregulator gene (genome locus FTL0552) was deleted in F. tularensis live vaccine strain
(LVS). The FTL0552 deletion mutant exhibited slightly reduced rates of extracellular
growth but was unable to replicate or survive in mouse macrophages and was avirulent in
the mouse model using either BALB/c or C57BL/6 mice. Mice infected with the
FTL0552 mutant produced reduced levels of inflammatory cytokines, exhibited reduced
histopathology and cleared the bacteria quicker than mice infected with LVS. Mice that
survived infection with the FTL0552 mutant were afforded partial protection when
challenged with a lethal dose of the virulent Schu S4 strain (4 of 10 survivors, day 21
post infection) when compared to naïve mice (0 of 10 survivors by day 7 post infection).
Microarray experiments indicate that 148 genes are regulated in the FTL0552 mutant.
Most of the genes are down regulated, indicating that FTL0552 controls transcription of
genes in a positive manner. The list of down regulated genes includes genes located
vii

within the Francisella Pathogenicity Island (FPI) that are essential for intracellular
survival and virulence of Francisella tularensis. Furthermore, a mutant in FTL0552 or
the comparable locus in Schu S4 (FTT1557c) may be an alternative candidate vaccine for
tularemia.

viii

Introduction

Francisella Species
Francisella tularensis is a small, non-motile, aerobic, gram-negative coccobacillus, the only genus belonging to the Family Francisellaceae and a member of the γsubclass of proteobacteria. This bacterium was first discovered by McCoy and Chapin in
1911 following an outbreak of a plague-like illness in ground squirrels in Tulare County,
California. There are two species within the Francisella genus: tularensis and
philomiragia (26, 44, 58). These bacteria are hardy, non-spore forming organisms, with a
thin lipopolysaccharide-containing envelope that can persist in the environment for long
periods of time in low temperature water, moist soil, hay, straw, and decaying animal
carcasses (www.bt.cdc.gov/agent/tularemia) (58). There are five subspecies of F.
tularensis found in the Northern Hemisphere but only two subsp., tularensis and
holarctica, cause human disease (58). The most virulent subsp., tularensis (type A), is
the causative agent of the zoonotic disease, tularemia. It is predominantly found in North
America and is associated with lethal pulmonary infections. Recently, studies further
divided the subsp. tularensis into two genetically distinct clades, type A1, found
predominantly in California, the midwest and Massachusetts, and A2, found
predominantly in California and the mountain states (58). The second subsp. holarctica
(type B), also known as palearctica, rarely causes a fatal disease in humans and is
1

predominantly found in Europe and Asia. An attenuated Live Vaccine Strain (LVS),
derived from a Russian strain of subsp. holarctica, has been described and shown to offer
protection to humans against naturally and laboratory acquired tularemia but remains as
virulent to mice as wild type subsp. holarctica (35). LVS causes disease in mice that is
virtually indistinguishable from that caused in humans by the highly virulent strains (5,
21, 29). The LVS strain is not fully licensed as a vaccine but is currently under review by
the U.S. Food and Drug Administration. It has been used as an investigational new drug
for persons at high risk for tularemia such as scientists working with F. tularensis. The
third subsp., novicida, has been characterized as a relatively non-virulent strain, with only
two documented cases of tularemia caused by novicida in two severely
immunocompromised patients in North America. The most recently identified subsp. of
Francisella is mediasiatica. It is primarily found in Asia but very little is know about this
subsp. or its association with human disease. F. philomiragia is a muskrat pathogen (58).

Francisella tularensis and Human Disease
F. tularensis is capable of infecting many invertebrates and vertebrates. Recent
discoveries revealed that F. tularensis is resistant to killing by the free-living amoebae,
Acanthamoeba castellanii, and this protozoa is the suspected source of outbreaks of
gastrointestinal and respiratory tularemia in humans in Norway (1, 8, 58). Humans can be
incidentally infected through direct contact with infected mammalian reservoirs or
through vectors such as ticks, mosquitoes, and deer flies. The most important
mammalian species responsible for human infection include muskrats, beavers, squirrels,
mice, voles (meadow or field mice) and lagomorphs (hares, rabbits and pikas) (58).
2

There are no cases of human-to-human transmission documented. The most common
form of the disease is ulceroglandular, which occurs through direct skin contact.
Consumption of contaminated food or water can lead to an oropharyngeal infection and
inoculation of the eye can lead to a conjunctival infection. The most severe form of
disease, pneumonic tularemia, develops from the inhalation of aerosolized bacteria, often
generated when handling infected animal carcasses, leading to the common reference to
the disease as “rabbit fever”. Brushcutting and lawn mowing or disturbing contaminated
areas can generate aerosolization of the bacteria. Worldwide incidence of naturally
occurring tularemia is unknown. In the U.S., reported cases have dropped sharply from
several thousand/year prior to1950 to fewer than 200/year in the 1990s (58).

F. tularensis Pathogenesis and Treatment
F. tularensis can infect humans through the skin, mucous membranes,
gastrointestinal tract, and lungs. It is a facultative intracellular bacterium that multiplies
within macrophages. Within the macrophage, the bacteria are capable of replicating to
high numbers before the onset of a protective cell-mediated immune response, a hallmark
of tularemia (35). The major target organs are the lymph nodes, lungs and pleura, spleen,
liver, and kidney. Untreated, bacilli inoculated into skin or mucous membranes multiply,
spread to regional lymph nodes, and further multiply, and then may disseminate to organs
throughout the body. Bacteremia may be common in the early phase of infection. The
initial tissue reaction to infection is a focal, intensely suppurative necrosis consisting
largely of accumulations of polymorphonuclear leukocytes, followed by invasion of
macrophages, epithelioid cells, and lymphocytes. Suppurative lesions become
3

granulomatous, and histopathological examination of the granulomas shows a central
necrotic, sometimes caseating, zone surrounded by a layer of epithelioid cells,
multinucleated giant cells, and fibroblasts in a radial arrangement, typical of other
granulomatous conditions such as tuberculosis and sarcoidosis. Humans with
inhalational exposures also develop hemorrhagic inflammation of the airways early in the
course of illness, which may progress to bronchopneumonia. Histopathological
examination of the lungs shows alveolar spaces filled with an exudate of mononuclear
cells. Pleuritis with adhesions and effusion and hilar lymphadenopathy are common in
radiological and pathological findings. Primary clinical forms vary in severity and
presentation according to virulence of the infecting organism, dose, and site of inoculum.
The onset of tularemia is usually abrupt, with fever (38oC–40oC), headache, chills and
rigors, generalized body aches (often prominent in the lower back), coryza, and sore
throat. Pulse-temperature dissociation has been noted in as many as 42% of patients. A
dry or slightly productive cough and substernal pain or tightness frequently occur with or
without objective signs of pneumonia, such as purulent sputum, dyspnea, tachypnea,
pleuritic pain, or hemoptysis. Nausea, vomiting, and diarrhea may occur. Sweats, fever,
chills, progressive weakness, malaise, anorexia, and weight loss characterize the
continuing illness (www.bt.cdc.gov/agent/tularemia).
Tularemia is treatable with antibiotics, with streptomycin as the drug of choice.
However, the time of onset of treatment and the route of infection determines the severity
and form of disease progression. Up to 60% of untreated infections can be fatal (58).
Gentamicin, which is more widely available and can be used intravenously, is an
acceptable alternative. Treatment with aminoglycosides should be continued for 10 days.
4

Tetracyclines and chloramphenicol are also used, but relapses and primary treatment
failures occur at a higher rate with these bacteriostatic agents than with aminoglycosides,
and they should be given for at least 14 days to avoid relapse. Both streptomycin and
gentamicin are recommended as first-line treatment of tularemia in children. In a mass
casualty setting, doxycycline and ciprofloxacin, administered orally, are the preferred
choices for treatment of both adults and children (www.bt.cdc.gov/agent/tularemia).

F. tularensis Live Vaccine Strain (LVS)
A live vaccine strain (LVS) has been used for immunization in the past, but is not
licensed for general use and does not provide complete protection (71). Problems with
the LVS include its failure to induce full immunity against all forms of tularemia (10),
and the effects of culture conditions on its attenuation (14). Although the origin and
source of the attenuation are not known, recent data suggest a possible genetic basis for
the reduced virulence of the LVS strain (70). The findings were based on identification
of sequence variations from comparisons between the genome of LVS to the closely
related strain, F. tularensis holarctica strain FSC200.

F. tularensis as a Bioweapon
Francisella tularensis has been classified by the United States Centers for Disease
Control and Prevention (CDC) Strategic Planning Group as a Category A agent of high
priority (37). F. tularensis is a candidate for bioterrorism because of its virulence, low
infective dose, and its potential for transmission by aerosols (37). In humans, an
infectious dose for type A strains can be as low as 10 bacteria for respiratory (57, 75) or
5

intradermal routes (76). In addition to naturally occurring outbreaks reported since the
mid-twentieth century, it is suspected that Japanese germ warfare research units studied
and may have deliberately used F. tularensis subsp. tularensis against Chinese civilians,
Russian troops and American prisoners of war between 1932 and 1945 (42, 58). Both the
United States and Russia stockpiled tons of infectious agents, including F. tularensis
subsp. tularensis, for potential use a bioweapons during the cold war (15, 42, 58).

F. tularensis Virulence Factors
Little is known about virulence mechanisms of F. tularensis (60, 78).
Francisella species are facultative intracellular pathogens that can survive phagocytosis
and multiply within host macrophages (27, 73, 77). The ability of Francisella species to
survive and multiply in macrophages plays a crucial role in its dissemination and
pathogenesis (4, 27). Immunity to F. tularensis infection is afforded primarily by a cellmediated response (33, 78), and is not induced by immunization with killed bacteria (83,
84).

Lipopolysaccharide (LPS)
Unlike E. coli lipopolysaccharide (LPS), F. tularensis LPS does not activate cells
to release pro-inflammatory cytokines via TLR4 and is 1000-fold less potent than LPS
from other enteric bacteria. Recent studies suggest that unique structural features within
the F. tularensis LPS lipid A backbone and core structure, as well as the insertion
element (IS-Ftu1) contained within the O-antigen gene cluster are responsible for the
phase variation and low bioactivity of Francisella LPS (Fig. 1) (3, 18, 46, 58, 72, 85, 90).
6

Figure 1. Structure of F. tularensis LPS. The lipid A of F. tularensis subsp. holarctica
strain 1547. Note the asymmetrical lipid A structure and the absence of O-acylation on
hexosamine II (arrow). The phosphogalactosamine substitution on the
4'-position of this hexosamine is also unique to Francisella (McLendon, M.K., M.A.
Apicella, and L.A. Allen, 2006).
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Type IV Pili
Type IV pili, on the surface of bacteria, help mediate attachment to host cells,
DNA uptake, twitching motility and biofilm formation. Microscopy revealed structures
resembling type IV pili on the surface of F. tularensis LVS and orthologs of genes
required for expression of the type IV pilus are present in the F. tularensis subsp.
tularensis Schu S4 genome. Deletion of the type IV pilin gene resulted in attenuated
virulence of the bacteria (25). However, the role of Francisella pili has yet to be
determined (11, 12, 31, 52, 58, 67). Although F. tularensis does not appear to secrete
toxins, homologs of pilin and pseudopilin genes associated with type II secretion, along
with 15 potential ATP-binding cassette system genes that may be involved in type I
secretion are present in the genome sequence of F. tularensis Schu S4 (31, 52, 58).

Francisella Pathogenicity Island (FPI)
The F. tularensis subsp. tularensis Schu S4 genome is approximately 1.9 Mb,
containing 1804 predicted coding sequences. More than 10% of the genes are
pseudogenes or gene fragments and there are five insertion elements scattered throughout
the genome, resulting in the disruption of more than half of the predicted metabolic
pathways (52, 58, 86). There is a unique 33.9-kb region, encoding 25 genes with no
known homologs, that is duplicated within the Schu S4 genome and is also present in
LVS and F. tularensis subsp. novicida. Disruption of genes within this region results in
attenuation of the bacteria’s ability to survive within host macrophages. The region is
termed the Francisella Pathogenicity Island (FPI) (34, 36, 51, 52, 65).
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Intracellular Survival
F. tularensis infects macrophages of humans, mice, rats, rabbits and guinea pigs.
Macrophages are believed to be the primary host cell for survival and replication of the
bacterium. Internalization of F. tularensis occurs via phagocytosis, mediated by large
asymmetric pseudopod loops projecting from the surface of the macrophage that encircle
the attached bacteria (16, 58). However, the exact niche occupied by this organism and
the specific virulence factors modulating the organism’s intracellular growth and survival
are not clearly defined (58). Once internalized, bacteria are maintained within a
phagosomal compartment, which would normally undergo a series of interactions with
early endosomes, late endosomes, and lysosomes to lead to the degradation of the
ingested bacteria. In contrast, LVS phagosomes transiently associate with early
endosomes, accumulate the late-endosome markers lamp-1, lamp-2, and CD63, but do
not mature further and do not acquire lysosomal hydrolases. At 3 to 4 hours following
ingestion, the late endosome markers, lamp-1 and CD63 begin to decline, the phagosome
membrane is disrupted and by 6 hours following ingestion, the bacteria begin to replicate
in the cytosol (Fig. 2) (2, 4, 17, 28, 32, 58, 74). How the phagosome membrane is
disrupted is yet to be defined. Recent studies identified a 23-kDa protein, encoded by the
intracellular growth locus (iglC) whose expression is up-regulated in macrophages. The
iglC gene is located within the IglABCD gene cluster that is a major component of the
FPI (34, 58, 65). The expression of FPI genes required for intramacrophage survival,
including iglB and iglC, is controlled by the macrophage growth locus A and B (MglA
and MglB) (54). MglA and MglB are transcriptional regulators controlling the
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expression of virulence genes. Introduction of a mglA mutation into F. tularensis subsp.
novicida identified 102 genes regulated by this factor alone (9).
Mutants in mglA, mglB, iglB, and iglC do not escape the phagosome, are impaired in
intracellular macrophage growth and are dramatically reduced in virulence in a mouse
model (7, 35, 36, 51, 54, 74).

10

Figure 2. Francisella tularensis phagocytosis and trafficking within the endocytic
pathway. Following bacterial engulfment, the phagosome particles first matures to an
early endosome (pH ~6.5) expressing Rab5 and EEA1, and then to a late endosome
expressing Rab7, Lamps, and M6PR. The non-acidified late-endosome-like phagosome
of Francisella tularensis does not fuse with lysosomes and is stable for 2-4 h, followed
by gradual disruption and bacterial escape into the cytoplasm, where replication occurs.
(www.biohealthbase.org/GSearch/imgs/image004.gif)
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Two-Component Signal Transduction Sytems (TCS)
The pathogen-host relationship is complex, and successful infection depends upon
the expression of a number of bacterial genes that are adapted for infection of the host
(23, 24, 43, 48). In the case of the vector-borne zoonotic bacterium F. tularensis, it must
survive and grow under a wide range of conditions including arthropod vectors, such as
ticks, as well as in warm-blooded vertebrate hosts. The synthesis of bacterial virulence
factors in these changing environments is highly regulated and responds to environmental
cues such as growth phase, temperature, osmotic stress and changing concentration of
extracellular ions such as Mg2+, Ca2+ and Fe2+ (59). Two component signal transduction
systems (TCS), reviewed by Stock et al. (82), are the most prevalent strategies bacteria
use to couple environmental signals to adaptive responses, and play an important role in
bacterial survival under environmental stress including survival within macrophages (61).
They typically contain a membrane bound sensor kinase and a cytoplasmic responseregulator. The sensor kinase detects environmental signals at the surface of the cells,
resulting in autophosphorylation of a histidine residue in the cytoplasmic C-terminal tail.
The response-regulator is comprised of two highly conserved domains, the
regulatory/receiver domain and the effector domain (Fig. 3A). The receiver domain acts
as a phosphorylation-activated switch that controls an associated effector domain. The
sensor kinase transfers the phosphate group to a conserved active-site aspartic acid
residue within the cytoplasmic response-regulator receiver domain, shifting the
equilibrium to an active state. Phosphorylation modifies the effector domain’s ability to
act as a DNA-binding, transcription activator controlling multiple genes (Fig. 3B) (79,
81). Inactivation of two component signal transduction systems results in reduced
12

bacterial virulence (38). For example, Salmonella phoP/phoQ genes control the
expression of more than 40 genes, including proteins encoded by virulence-associated
genes important for intramacrophage survival during infection (55, 62). The PhoQ
sensor kinase responds to changes in external stimuli, including magnesium
concentrations, to activate the PhoP response-regulator, and results in the transcription of
genes essential for survival of the bacteria in the changing environment (79). PhoP also
controls virulence in Yersinia pestis (68), Shigella flexneri (64), Myocobacterium
tuberculosis (69), Bordetella pertussis (47), and N. meningitidis (45, 66). A TCS
response-regulator, PmrA has been recently described in Francisella tularensis subsp.
novicida. PmrA is an orphan member of typical two-component regulatory systems.
PmrA shares high similarity (44%) with the Salmonella PmrA response-regulator. F.
novicida mutants lacking the pmrA gene were defective for survival and growth within
macrophages and offer complete protection in mice against homologous challenge but
did not protect the mice against challenge with the Schu S4 strain. DNA microarray
analysis identified 65 genes regulated by PmrA, some of which are located within the FPI
(63).
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A

B

Figure 3. TCS. (A) F. tularensis FTL0552 response-regulator conserved signal receiver
and effector domains. (B) The sensor kinase detects environmental signals at the surface
of the cells, resulting in autophosphorylation. The sensor kinase transfers the phosphate
group to a conserved active-site aspartic acid residue within the cytoplasmic responseregulator receiver domain, modifying the effector domain’s ability to act as a
transcription activator for several genes
(www.bio.vu.nl/hwconf/IntrBCA00/img052.GIF).
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Objectives

Very little is known about the molecular mechanisms of F. tularensis
pathogenesis (53). A live vaccine strain (LVS) has been used for immunization in the
past, but has failed to induce full immunity against laboratory acquired tularemia and is
not approved for use against the disease (10, 89). The LVS is an attenuated strain of F.
tularensis subsp. holarctica (type B). The reasons for attenuation and immunological
basis for the efficacy of the LVS strain are not fully understood (53, 78, 87, 89).
Immunity to F. tularensis infection is a cell-mediated immunity, with a very complex
pathogen-host relationship (23, 24, 48). Successful infection depends on the coordinated
expression of bacterial genes in response to the host cell environment (43). F. tularensis
is able to respond to and exploit host cell functions in a process that avoids phagocytosis
and permits the bacteria to survive and replicate within the host cell (53). The genes that
facilitate the survival and replication of Francisella within the host cell play a crucial role
in pathogenesis. In Francisella tularensis, they are part of a very highly regulated system
that is adapted to respond to environmental cues such as growth phase, temperature,
changes in metal ion concentrations, and pH (56, 59).
Bacterial survival within macrophages is highly dependent on genetic systems
that respond to environmental stress (91). Two component genetic systems have been
shown to be important for bacteria experiencing environmental stress by mediating signal
15

transduction necessary to allow survival within macrophages (38, 61). Inactivation of
two component signal transduction systems results in changing the cell physiology and
modulating transcriptional activation of critical virulence genes (38, 61).
The S. typhimurium PhoPQ system has been the most widely studied two-component
signal transduction system (38, 61, 69, 91).
Bioinformatics revealed a putative phoP coding sequence in F. tularensis LVS
with significant homology to a consensus PhoP amino acid sequence derived from the
alignment of PhoP from other Gram-negative bacteria. Subsequent sequencing of the
LVS genome sequence identified a potential two-component response-regulator
(FTL0552).
The generation of a mutant F. tularensis strain that may be significantly reduced
in virulence but still able to produce an immune response will be useful in the
development of an improved live vaccine strain licensed for use against tularemia.
Hypothesis: Locus FTL0552 of Francisella tularensis LVS controls transcription of
genes whose products are necessary for the full virulence of this bacterium. The
following aims were developed in order to refute or support this hypothesis.
AIM 1 – Construct a knockout mutant in the F. tularensis LVS FTL0552. Determine if
the mutant has altered phenotypic properties similar to those predicted for the phoP gene
from other Gram-negative bacteria.
A. Construct a mutagenic plasmid that will be introduced into the recipient strain
by conjugation with selection for the inactivated phoP gene and allelic
replacement of the wild-type gene with the mutant allele.
B. Determine the growth properties for the mutant.
16

C. Analyze the response to varying levels of Mg2+ as compared to the wild type.
D. Analyze in vitro susceptibility to antimicrobial peptides and pH changes as
compared to wild type.
AIM 2 – Examine the FTL0552 mutant to analyze the role F. tularensis LVS FTL0552
plays in pathogenicity and immunogenicity.
A. Perform in vitro survival and replication studies in macrophages.
B. Perform in vivo studies to determine the ability of the mutant to cause disease
in a mouse model.
a. Perform time to death study of mice infected with the mutant.
b. Perform bacterial clearance studies.
c. Perform histopathological evaluation.
C. Determine if the mutant is able to confer protection of infected mice.
a. Challenge the infected mice with LVS and the fully virulent strain.
b. Determine the cytokine profile of infected mice.
AIM 3 – Identify F. tularensis LVS genes whose expression is controlled by FTL0552.
A. Perform gene microarray studies for mutant and LVS wild type.
B. Compare cell lysate and supernatant proteins in LVS wild type and mutant.
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Materials and Methods

Bacterial Strains.
F. tularensis LVS, kindly provided by Scott Bearden, CDC, Fort Collins, CO, was
grown on agar consisting of GC agar base (Remel, Lenexa, KS) supplemented with 5%
fetal bovine serum, 1% bovine hemoglobin and 1% IsoVitaleXTM (Becton Dickinson,
Sparks, MD), incubated at 37ºC. The F. tularensis LVS FTL0552 mutant was grown on
the same agar with the addition of 50µg/ml kanamycin. For some experiments, bacteria
were grown in Mueller Hinton II (MH) broth (Becton Dickinson, Sparks, MD)
supplemented with 0.1% glucose, 2% IsoVitaleXTM and 33 µM ferric pyrophosphate
(56). For bacterial growth analysis, MH broth cultures were incubated at 37ºC with
aeration and the OD550 was measured at various time points.

Cell Lines.
The immortalized mouse macrophage cell line (J774A.1) was cultured in
Dulbecco’s Modification of Eagle’s Medium (DMEM), supplemented with 10% fetal
bovine serum (FBS), 4.5g/mL glucose and L-glutamine, and 50µg/ml penicillinstreptomycin. Mouse peritoneal exudate cells (PEC) were collected from thioglycolate
treated BALB/c mice, washed and resuspended in medium containing, 10% FBS, 0.33
µl/ml 2-mercaptoethanol, and L-glutamine.
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Construction of pPVNot/Erm.
A plasmid derivative of pPV was constructed that has an added Not I restriction
site and has the erythromycin resistance gene (ErmR) substituted for chloramphenicol
resistance (CmR). To accomplish this task pPV shuttle vector (CmRApR) was kindly
supplied by Drs. I. Golovliov and Anders Sjöstedt (35). This plasmid was used to
transform an E. coli DH5α recipient to chloramphenicol resistance. pPV DNA was
prepared from an E. coli DH5α transformant, and subsequently altered to introduce a Not
I cloning site. The pPV vector has unique Sal I and Xba I cloning sites. An adaptor was
designed that could be ligated to Sal I and Xba I cleaved pPV DNA to generate a Not I
site. Oligonucleotides P327 and P328 were annealed to produce adaptors (Table 1), and
were ligated into pPV that had been cleaved with both Sal I and Xba I and transformed
into E. coli DH5α with selection for chloramphenicol resistance. The presence of the NotI
site was confirmed by restriction analysis and the resulting plasmid designated pPVNot.
This resulted in a mobilizable plasmid with unique Not I, Sal I and Xba I sites. A
derivative of pPVNot was constructed that had the CmR marker replaced with ErmR.
pPVNot was partially digested with Hind III, re-ligated and transformed into E. coli
DH5α with selection for ampicillin resistance. Colonies were screened for the loss of
chloramphenicol resistance and the loss of (only) the 3.2 kb Hind III fragment which
carries Cm resistance. This plasmid (ApR, CmS) was linearized by partial digestion with
Hind III, and ligated to the ermC gene from pKS65. pKS65, the source of ermC was
generously provided by Dr. Joseph Dillard (41), (University of Wisconsin Medical
School Madison, WI). Transformants were scored for both ampicillin and erythromycin
resistance on LB agar plates containing 200 µg/ml erythromycin and 100 µg/ml
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ampicillin. The resulting plasmid was designated pPVNot/Erm and this plasmid was
used for gene transfer into F. tularensis LVS.
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Table 1. Oligonucleotides used in this study.
Oligonucleotide
P327
P328
Left-F

Left-R

Right-F

Right-R
Kan-F
Kan-R
FTL0552-F
FTL0552-R

FTL0552+1100-F

FTL0552+1100-R
lepB-F
lepB-R
rnr-F
rnr-R
mutS-F
mutS-R
Operon 1-F
Operon 1-R
Operon 2-F
Operon 2-R
Operon 3-F
Operon 3-R
Operon 4-F
Operon 4-R

Purpose/comments
Forms adaptor with P328 to
introduce Not I site into pPV1
Forms adaptor with P327 to
introduce Not I site into pPV1
Amplify 5’ flanking region
upstream of FTL0552, contains
Not I site
Amplify 5’ flanking region
upstream of FTL0552, 5’
overhang of primer contains
kanR sequences
Amplify 3’ flanking region
downstream of FTL0552, 5’
overhang of primer contains
kanR sequences
Amplify 3’ flanking region
downstream of FTL0552,
contains Not I site
Amplify the kanR gene from
PBBR1MCS2
Amplify the kanR gene from
PBBR1MCS2
Amplify region within FTL0552
gene to confirm gene knockout
and for RT-PCR
Amplify region within FTL0552
gene to confirm gene knockout
and for RT-PCR
Amplify region outside area of
recombination to confirm
integration of FTL0552::kanR in
the chromosome
Amplify region outside area of
recombination to confirm
integration of FTL0552::kanR in
the chromosome
Amplify gene downstream of
FTL0552 for RT-PCR
Amplify gene downstream of
FTL0552 for RT-PCR
Amplify gene downstream of
FTL0552 for RT-PCR
Amplify gene downstream of
FTL0552 for RT-PCR
House keeping gene for RTPCR
House keeping gene for RTPCR
Overlapping FTL0552 and lepB
Overlapping FTL0552 and lepB
Overlapping lepB and rnc
Overlapping lepB and rnc
Overlapping rnc and truB
Overlapping rnc and truB
Overlapping truB and rnr
Overlapping truB and rnr

Sequence 5’ to 3’
TCGACATGCGGCCGCATT
CTAGAATGCGGCCGCATG
GCGCGGCCGCGACTCATTCAGTATCTGGGA
CGGCAAGAAAGCCATCCAGTCATCTTCAGCCAACAATATTC
TCAT
GCGGGACTCTGGGGTTCGAAAGGTGTTGGTTACTTTGTACA
AAAGG
GCGCGGCCGCTGGGACTCTAAGGTTTTCAA
ACTGGATGGCTTTCTTGCCG
TTTCGAACCCCAGAGTCCCGC
TTCAGATGGTGAGGCAGCGCAAA
CTTTGGTTACCGTTTCAGAGCTTGG

CGGTGCAAAGACAGGAAAAC

GTGACCGCCCTGTTCACTA
GCTGATCAGGCGAGATCTTT
AATTACATCGCCAGGCAAAC
ACCAAGCTAGGCAAGAACGA
TGCTAAAGCTTTGGGAGTCA
GTGGCGTCATCAAAGAAGGT
CGGGCTAGCGCCTTTTCTTT
AGACTATTAGAGGTGTTGGTTACTTTG
CTCATGTTTAACTCCATCAAGGTTT
AATGTTGACAATAAATGGTAAAAAACT
TCGATATTATTGGCTGATACCATTT
TTGGCTGAAGGAAAACTATCG
AGAGGTTGTCCATTATATTTAAGAGCT
AAGCATTAACATTCCTGAGTTATCTG
TGCACCCAAACGATTTACAA
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Identification of the FTL0552 response-regulator gene.
Bacterial PhoP protein sequences were retrieved from (NCBI) GenBank and
aligned using the PileUp Program for aligning multiple sequences from the Genetics
Computer Group (GCG) Wisconsin Package Version 10) (19, 22). The consensus
sequence, generated from the alignment of bacterial PhoP proteins, was used to search
the TIGR Comprehensive Microbial Resource (CMR) with the PhoP consensus sequence.
This search brought up PhoP proteins and confirmed the specificity of the consensus
sequence. A gapped BLAST search (3) of the Schu S4 and LVS genomes with the
consensus sequence identified candidate phoP genes. A phoP homologue was identified
with 26% identical deduced amino acid sequences and shown to have motifs consistent
with response-regulator proteins, containing both a response-regulator receiver domain
and a transcriptional regulatory protein domain. This amino acid sequence is highly
conserved in the Schu S4 (FTT1557c) genomic sequence.

Construction of the pPV-FTL0552 knockout plasmid.
A modified version of a previously described method using PCR products to
generate a knockout plasmid was used (53, 80). The flanking sequence consisting of
approximately 700 bp upstream and 700 bp downstream of FTL0552 were amplified
from F. tularensis LVS genomic DNA in two separate PCR reactions, using EasyStart
100 pre-aliquoted PCR reagents (Molecular BioProducts, San Diego, CA). The primer
sequences for the 5’ flanking regions were Left-F and Left-R and the primer sequences
for the 3’ flanking sequences were Right-F and Right-R (Table 1). A third PCR product
consisting of the kanamycin resistance gene was amplified from pBBR1MCS2 (49),
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using primers Kan-F and Kan-R. All three products were gel-purified using Geneclean
Turbo (MP Biomedicals, LLC., Solon, OH) and were used as templates in a PCR reaction
to generate a single product with upstream and downstream flanking regions of FTL0552
and most of the coding region (including nucleotides 26-645) replaced with kanR (Fig. 4).
This PCR product was generated using primers Left-F and Right-R and is flanked by Not
I restriction sites. The entire PCR product was 2349 base pairs in length. The resulting
PCR product was cleaved with Not I and ligated into the Not I site of pPVNot/Erm and
transformed into E. coli JM109. Plasmid DNA was prepared with the GenElute HP
Plasmid Midiprep Kit (Sigma, St. Louis, MO). The plasmid construct was confirmed by
digestion with Not I and then transformed into E. coli S17-1.

Delivery of FTL0552::kanR into F. tularensis LVS.
A previously described strategy for allelic replacement was used (35). The
resulting plasmid with the FTL0552 coding sequence interrupted by the kanR gene was
introduced into E. coli S17-1 for mobilization and transfer to LVS (Fig. 4). Conjugation
and selection were performed on supplemented GC agar plates containing 100µg/mL
polymyxin B and 25µg/mL kanamycin. Isolated colonies were spotted on plates
containing 5% sucrose, kanamycin (25 µg/ml), and polymyxin B (100 µg/ml) for
counterselection with sacB. Colonies that were both kanamycin and sucrose resistant
were verified by PCR and used for further analysis.
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Figure 4. Schematic representation of the strategy used for generation of the
FTL0552 deletion mutants. The 5’ and 3’ flanking regions of FTL0552 gene were
amplified from the F. tularensis LVS genomic DNA. The primers used for the
amplification of the regions flanking the FTL0552 gene regions and kanamycin
resistance gene (kanR) were designed with short overlapping sequences to the kanR gene
derived from pBBR1MCS2 (28). The resulting three amplicons were gel-purified and
used as template to amplify a PCR product with the kanR gene replacing FTL0552 (PCR
product #4). This product was digested with NotI and ligated into the suicide plasmid
pPVNotErm (see text). The resulting plasmid was introduced into F. tularensis LVS by
transconjugation from E. coli.
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RNA Extraction.
RNA was isolated from Mueller Hinton broth cultures of F. tularensis LVS
parental strain and FTL0552 mutant grown overnight to log phase (OD550 of 0.600).
RNA was isolated using TRIzol reagent (Invitrogen, Carlsbad, CA). The aqueous phase
was used in the RNeasy clean-up protocol (Qiagen, Valencia, CA) with a 15 minute
DNase digestion step (Qiagen, Valencia, CA) (9). The concentration of the RNA was
assessed at OD260 and OD280, and the integrity of the 23S and 16S rRNA was verified on
a 0.7% agarose gel.

RT-PCR analysis of FTL0552 and downstream genes.
Primers were designed for the second and fifth gene immediately downstream of
FTL0552 (Table 1). RT-PCR was performed using the One-Step RT-PCR kit (Qiagen,
Valencia, CA). Primers FTL0552-F and FTL0552-R (specific for FTL0552), primers
lepB-F and lepB-R (specific for lepB), primers rnr-F and rnr-R (specific for rnr) and
primers mutS-F and mutS-R (specific for the reference house keeping gene, mutS) were
used to reverse transcribe and amplify the cDNA synthesized from RNA isolated from
both the F. tularensis LVS parental strain and the FTL0552 mutant. The products’ sizes
are 352 bp for FTL0552, 288 bp for lepB, 314 bp for rnr and 304 bp for mutS. The
conditions for reverse transcription and amplification were 50ºC for 30 minutes and 95ºC
for 15 minutes, followed by 30 cycles of 94ºC for one minute, 55ºC for 1 minute and
68ºC for 1 minute, then a final elongation step of 72ºC for 10 minutes. For each primer
set, reactions lacking reverse transcriptase were performed to detect DNA contamination.
PCR products were run on a 1.0% agarose gel.
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RT-PCR analysis of F. tularensis LVS operon transcript.
Overlapping primers were developed to determine if FTL0552 and the four genes
immediately downstream are transcribed as one contiguous transcript. The four sets of
primers, operon 1, operon 2, operon 3, and operon 4, were designed to produce
overlapping PCR products ranging from 700-900 base pairs in size (Table 1). RNA was
extracted as previously described. An additional DNase treatment was performed prior to
reverse transcription by adding DNase to each RNA sample and heating for 10 minutes at
37ºC. The conditions for reverse transcription and amplification were 50ºC for 30
minutes and 95ºC for 15 minutes, followed by 35 cycles of 94ºC for one minute, 55ºC for
1 minute and 68ºC for 1 minute, then a final elongation step of 72ºC for 10 minutes. For
each primer set, reactions containing no RNA and no reverse transcriptase were
performed to detect DNA contamination. PCR products were run on a 0.7% agarose gel.

Intracellular Survival Assay.
The method for assessing intracellular growth of F. tularensis LVS in
macrophages was performed with minor modifications of the method previously
described by Golovliov et al. (34). J774A.1 mouse macrophage cells suspended in
DMEM media (Dulbecco’s Modification of Eagle’s Medium (DMEM), 10% FBS,
4.5g/mL glucose and L-glutamine) were seeded into a 24 well tissue culture plate at a
density of 6x104 cells/well and incubated overnight at 37ºC with 5% CO2. F. tularensis
LVS parental and FTL0552 mutant strain were suspended in DMEM, added to each well
at an MOI of 100, and allowed to infect for 2 hr at 37ºC in 5% CO2. Following infection,
the cells were washed twice with PBS to remove extracellular bacteria. Gentamicin
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(50µg/ml) was added to the wells and the incubation was allowed to continue for 1 hr.
Thereafter, the cells were washed once with PBS and media containing gentamicin
(2µg/ml) was added to the wells. At various time points (0, 24, 48 and 72 hrs) the cells
were washed with PBS and lysed with 0.1% sodium deoxycholate. Viable counts were
performed by plating serial 10-fold dilutions of the lysates on supplemented GC agar
plates and incubating at 37ºC (34). All experiments were performed in triplicate. The
data are representative of three independent experiments. Infection of peritoneal exudate
cells (PECs) was performed with modifications of the method described by Twine et al.
(89). Peritoneal cells (PC) were collected from thioglycolate treated BALB/c mice,
washed and resuspended in medium containing, 10% FBS, 50µM 2-mercaptoethanol, and
L-glutamine. PC cell suspensions were seeded into a 96 well tissue culture plate at a
density of 1x105 cells/well and incubated overnight at 37ºC in 5% CO2. F. tularensis
LVS and FTL0552 mutant bacteria were added to each well at an MOI of 50 and allowed
to infect for 1.5 hrs. The cells were then washed twice with HBSS to remove
extracellular bacteria. Medium containing gentamicin (50µg/ml) was added to the wells
and incubated for 1 hr. Thereafter, the cells were washed once with HBSS and cultured
in medium containing gentamicin (2µg/ml). At various time points, (0, 12, 24 and 48
hrs) the cells were washed with HBSS and lysed with 0.1% saponin. Viable counts were
performed by plating serial 10-fold dilutions of the lysates on supplemented GC agar
plates and incubating at 37 ºC (32). All experiments were performed in triplicate.
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Fluorescence Microscopy.
FTL0552 mutant was stained with PKH67 green fluorescent cell linker mini kit
(Sigma St. Louis, MO) as per the manufacturer’s instructions. LVS transformed with a
GFP containing plasmid was used a control. 1x104 MH-S (murine alveolar macrophage
cell line) cells in RPMI-1640 supplemented with 10% FBS (Invitrogen Inc, Carlsbad,
CA) were seeded on a sterile Lab-Tek chamber slide (Nalge Nunc International,
Rochester NY) and incubated for 12 hr at 370C. The cells were infected with the labeled
FTL0552 or the GFP-LVS at an MOI of 100 and incubated at 370C for 15, 30 and 45
minutes. Uninfected cells served as controls. After each indicated time, the cells were
washed twice with sterile PBS and fixed with 3% paraformaldehyde. The MH-S cells
were counterstained with PKH26 red fluorescence cell linker mini kit (Sigma St. Louis,
MO) as per the manufacturer’s instructions. The cells were washed, mounted with the
coverslips and observed under a fluorescent microscope. For confocal microscopy 0.5
µM Z sectioning was performed on a confocal microscope (Carl Zeiss Laser Scanning
System, Biocompare Inc., San Francisco, CA). The slides were observed under a CApochromat objective at 40x magnification with 1.2 W corrections and visualized in
channel-1 at 500-550 IR and channel-2 at 565-615 IR. The images were analyzed using
LSM5 image browser software version 3,2,0,115 (Carl Ziess, Biocompare Inc., San
Francisco, CA).
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Magnesium Assay.
LVS parent strain and FTL0552 mutant cultures were grown at 37ºC in 5mL MH
broth containing increasing concentrations of magnesium (0-500µM). After 18-24 hours,
the OD550 was measured to assess growth.

pH Assay.
LVS parent strain and FTL0552 mutant cultures were grown at 37ºC in 5mL of
MH broth at varying pH levels (6.5-4.0). After 18-24 hours, the OD550 was measured to
assess growth.

Hydrogen Peroxide Killing Assay.
LVS wild type and FTL0552 mutant bacteria was cultured at 37ºC in MH broth to
log phase (OD550 of 0.6) and diluted 1:100 in MH broth before mixing 50µl of each
bacterial culture with 50µl of 30mM hydrogen peroxide in MH broth or with 50µl of MH
broth alone (untreated control). The mixture was incubated at 37ºC in a 96 well culture
plate and samples were collected at times points 0, 5, 10, 20, and 30 minutes. Serial
dilutions of the samples at each time point were plated on GC agar plates to determine
viable colony forming units.
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Determination of FTL0552 mutant Polymyxin B Minimum Inhibitory
Concentration (MIC).
LVS wild type and FTL0552 mutant bacterial cultures were incubated at 37ºC
with agitation overnight in 5mL of MH broth supplemented with various concentrations
(15.6µg/mL - 1000µg/mL) of polymyxin B. OD550 measurements were taken at 18-24
hours to determine the MIC.

Mouse infection.
Six to eight week-old BALB/c and C57BL/6 mice (Taconic, Germantown, NY) of
either sex were housed in a specific pathogen free environment in the Animal Resource
Facility at Albany Medical College and used for screening of the FTL0552 mutant. A
frozen aliquot of F. tularensis LVS or F. tularensis LVS FTL0552 mutant was thawed
and diluted in sterile PBS. Prior to intranasal (i.n.) inoculation, the mice were deeply
anesthetized via intraperitoneal injection of a cocktail of Ketamine (20mg/ml) and
Xylazine (1 mg/ml). The mice (n=10 for each group) were infected i.n. with 1x104 or
1x105 CFU of LVS or FTL0552 mutant in a volume of 20 µl PBS (10 µl per nare). The
mice were monitored closely for morbidity and mortality for a period of 21-30 days postinfection and the median survival time (MST) was calculated for each group of mice.
Mice that survived the initial infection dose of 1x105 CFU of FTL0552 mutant were
challenged with 1x102 CFU of the virulent F. tularensis Schu S4 strain. All mice that
survived 1x104 CFU of FTL0552 mutant were boosted with 1x105 CFU of FTL0552
mutant and challenged 30 days later with 1x102 CFU of Schu S4. Actual numbers of
bacteria were determined by plating the inoculum after primary infection and challenge.
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All the Schu S4 challenge experiments were carried out in the ABSL-3 facility of the
Albany Medical College following standard operating procedures.

All experiments

conformed to the animal procedures approved by Institutional Animal Care and Use
Committee guidelines
A time course experiment was conducted to determine the kinetics of bacterial
clearance. BALB/c and C57BL/6 mice were infected i.n. with 5x103 CFU of either LVS
or FTL0552 mutant. A group of four mice each was sacrificed at days 1, 3, 5 and 7 postinfection. Lung, liver and spleen were collected aseptically for quantitation of bacterial
burden and histology at the indicated times.

Quantification of F. tularensis burden.
Bacterial burdens were quantified in the lungs, livers and spleens of C57BL/6 and
BALB/c mice. The lungs from the infected mice were inflated with sterile PBS and
collected aseptically in PBS containing a protease inhibitor cocktail (Roche Diagnostics,
Indianapolis, IN). Livers and spleens were also collected in a similar fashion. The
organs were subjected to mechanical homogenization using a Mini-BeadBeater-8™
(BioSpec Products Inc., Bartlesville, OK). The tissue homogenates were spun briefly at
1000 x g for 10 sec in a microcentrifuge to pellet the tissue debris. Supernatants were
diluted 10-fold in sterile PBS and 10 µl of each dilution were spotted onto chocolate agar
plates in duplicate and incubated at 37°C for 2-3 days. The number of colonies on the
plates were counted and expressed as CFU/gram of tissue.

The remaining tissue

homogenates were spun at 14000 × g for 20 min and the clarified supernatants were
stored at -20°C and used for measurement of tissue cytokine levels.
31

Histopathology.
The lungs, livers, and spleens from infected mice were excised at days 1, 3, 5 and
7 post-infection and fixed with 10% neutral buffered formalin. Lungs were inflated via
instillation of PBS into the trachea prior to fixation. Tissues were processed using
standard histological procedures and 5 µm paraffin sections were stained with
hematoxylin-eosin and examined by light microscopy.

Cytokine measurement.
Mouse Inflammation Cytometric Bead Array (CBA) Kits (BD Bioscience, San
Diego, CA) were used for the simultaneous measurement of multiple cytokines in lung
homogenates of BALB/c and C57BL/6 mice infected either with LVS or FTL0552
mutant. Data were acquired on a FACSArray (BD Immunocytometry Systems) and
analyzed using CBA software version 1.1.

Gene Microarray analysis.
RNA was extracted from broth cultures grown to log phase using the Enzymatic
Lysis and Proteinase K Digestion of Bacteria protocol from the RNAprotect Bacteria
Reagent Handbook (Qiagen, Valencia, CA), followed by purification using the RNeasy
Mini Kit Purification of Total RNA from Bacterial Lysate protocol (Qiagen, Valencia,
CA). cDNA was synthesized from 1µg of total RNA in a standard reverse transcription
(RT) reaction using 5 µg of random hexamers (Amersham Biosciences, Piscataway, NJ)
and Superscript III (Invitrogen). Amino allyl dUTPs were incorporated at this step (2.5
mM dATP, 2.5 mM dCTP, 2.5 mM dGTP, 1 mM amino allyl dUTP, and 1.5 mM dTTP)
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(Invitrogen). cDNA was purified using Zymo DNA purification columns as specified by
the manufacturer (Zymo Research Corp., Orange, CA), and samples were labeled with
Cy5 (red) fluorophores and the reference was labeled with Cy3 (green) fluorophores
(Amersham Biosciences). Unincorporated fluorophores were quenched using 5µl of 4M
hydroxylamine and incubated in the dark for 15 min. The samples were then combined,
and unincorporated dyes were removed using Zymo DNA purification columns. For
hybridization, cDNA was eluted in 19µl of Tris-EDTA buffer, and 2µl of 20mg/ml yeast
tRNA (Invitrogen), 4.25 µl of 20× SSC, and 0.75µl of 10% sodium dodecyl sulfate were
added to the probe. Probes were denatured for 2 min at 99°C, spun at 17,900 × g, and
cooled at room temperature before they were added to the arrays. The samples and arrays
were incubated at 60°C for ~14 h, and stringency washes were performed. Briefly, the
arrays were washed for 2 min each in a series of four washes with increasing stringency:
(i) 2× SSC-0.03% sodium dodecyl sulfate, (ii) 2× SSC, (iii) 1× SSC, and (iv) 0.2× SSC.
The microarrays were scanned and analyzed using a Gene Pix 4000A scanner and
GENEPIX5.1 software (both from Axon Instruments, Redwood City, CA). Normalized
data were collected using the Stanford Microarray Database. Spots were excluded from
analysis due to obvious abnormalities, a regression correlation of <0.6, or a Cy3 net mean
intensity of <100. Only spots with at least 70% good data across the experiment were
included for analysis. The ratios of the red channels to green channels for each spot were
expressed as log2 (red/green) and used for hierarchical clustering using the CLUSTER
program. Results were visualized using the TREEVIEW program. Using data from all
of the microarrays, significant differences between the wild-type and mutant were
determined using the Significance Analysis for Microarrays (SAM) program, v. 1.21.
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Using the two-class statistical analysis tool in the SAM program, a list of genes whose
transcript levels were significantly increased or decreased between the two groups was
calculated. A calculated false discovery rate of <1% was used to assign significance, and
a two-fold cutoff in the change in expression level was imposed.

Silver Stain of SDS-PAGE gel.
F. tularensis LVS parent strain and FTL0552 were grown in MH broth cultures to
log phase and spun down at 2500 rpm for 10 minutes to pellet the bacterial cells. The
supernatant was removed, filter-sterilized, and concentrated in a Centricon-Plus-20
Centrifugal Filter Unit (Millipore Corporation, Billerica, MA).

Cell lysate and

concentrated supernatant samples were prepared using the NuPAGE® Novex® Bis-Tris
Gel protocol (Invitrogen, Carlsbad, CA). Briefly, NuPAGE® LDS Sample Buffer (4x),
NuPAGE® Reducing Agent (10x) and deionized water was added to each sample and
heated for 10 minutes at 70ºC.

1x SDS Running Buffer was prepared using 20x

NuPAGE® MES and deionized water. 10µg or 20µg of each sample was loaded on a 412% NuPAGE® Novex® Bis-Tris Mini Gel (Invitrogen, Carlsbad, CA) and
electrophoresis was performed according to manufacturer’s instructions. The gel was
fixed, washed, and stained according to manufacturer’s instructions using the Silver Stain
Plus Kit (Bio-Rad Laboratories, Inc., Hercules, CA).
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Statistical analyses.
The survival results are expressed as Kaplan-Meier curves and P values were
determined using a Log-Rank test. All other results were expressed as mean ± SEM and
comparisons between the groups were made using one-way ANOVA followed by
Bonferroni’s correction, nonparametric Mann-Whitney test, or Student’s t-test.
Differences between the experimental groups were considered significant at P< 0.05
level.
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Results

Identification of the response-regulator gene.
Dr. Jean Citron first identified a putative response-regulator in the F. tularensis
subsp. tularensis Schu S4 genome by homology with a consensus PhoP amino acid
sequence derived from alignment of the deduced peptide sequence from other Gramnegative bacteria. The FTT1557c locus from the Schu S4 genome sequence was
identified and shown to have motifs consistent with response-regulator proteins,
containing both a response-regulator receiver domain and a transcriptional regulatory
protein domain. Prior to publication of the F. tularensis LVS genome, Dr. Citron
obtained the incomplete LVS genome sequence from Dr. Emilio Garcia from Lawrence
Livermore National Laboratories. Dr. Citron compiled a file aligning the overlapping
LVS sequence contigs to begin searching against the database for possible homologs to
FTT1557c and other possible virulence regulator genes. It was with this alignment that
she first identified potential genes in F. tularensis LVS sharing homology with the
derived consensus PhoP sequence, as well as other genes associated with virulence
regulation in gram negative bacteria, such as, rpoH (RNA polymerase sigma factor), and
qseA (quorum sensing Escherichia coli regulator A). Upon publication of the LVS
genome sequence, she was able to confirm the presence of the coding sequence for a
putative response-regulator protein (FTL0552 in LVS and FTT1557c in Schu S4)
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identified by homology with a consensus PhoP amino acid sequence derived from
alignment of the deduced peptide sequence from other Gram-negative bacteria. The
FTL0552 locus from the F. tularensis LVS genome sequence was identified and shown
to have motifs consistent with response-regulator proteins, containing both a responseregulator receiver domain and a transcriptional regulatory protein domain. The locus is
annotated as a two-component response-regulator, however, no sensor histidine kinase
gene can be identified in the area immediately upstream or downstream of this gene (Fig.
5). Recent studies identified 16 genes in Francisella spp. involved in environmental
signal transduction and only 4 appear to share homology with known TCS sensor
histidine kinases or response-regulators. None of the TCS genes appear to be paired in
the genome as typical TCS operons in other Gram negative bacteria (63). Although the
locus was identified by homology with a PhoP consensus sequence, FTL0552 shares
homology with other response-regulator proteins (63). The gene arrangement of adjacent
genes and the deduced amino acid sequence homology of this putative response-regulator
gene is highly conserved between LVS and the virulent F. tularensis Schu S4 strain
(locus FTT1557c shows only one conservative amino acid change in residues 21-228).
The putative response-regulator gene (FTL0552) is the first gene in a series of five that
appear to form a single operon with minimal intergenic spaces or in some cases
overlapping genes (Fig. 5). RT-PCR revealed that FTL0552 and the four downstream
genes are transcribed as one complete transcript, suggesting that FTL0552 is the first
gene of a five gene operon, transcribed from the same promoter (Fig. 6). The amplicon
using primers specific for the region from lepB to rnc, appears weak and is most likely
due to the primer design and not the level of transcription for that region.
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response
regulator

Figure 5. Arrangement of FTL0552 and adjacent genes on the F. tularensis LVS
genome (NC007880). The genome locus tags are indicated as are the size of the genes in
base pairs (top) and the intergenic space between genes (below). The genes indicated are
(as annotated on the genome sequence): Ψ; pseudogene; putative response-regulator,
lepB; signal peptidase I, rnc; RNase III, truB; tRNA pseudouridine synthetase B, rnr;
RNaseR, and oleI; delta9 acyl-lipid fatty acid desaturase. The gene arrangement is
suggestive of a five-gene operon transcribed from a promoter region upstream of
FTL0552.
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Figure 6. mRNA of FTL0552 and the four downstream genes forms one complete
transcript. RT-PCR analysis of F. tularensis LVS, utilizing overlapping primers, was
performed to determine whether FTL0552 is part of a five gene operon under the control
of the same promoter. Lane 2; amplicons using primers specific for the region from
FTL0552 to lepB (operon 1-F and operon 1-R), lane 3; amplicons using primers specific
for the region from lepB to rnc (operon 2-F and operon 2-R), lane 4; amplicons using
primers specific for the region from rnc to truB (operon 3-F and operon 3-R), lane 5;
amplicons using primers specific for the region from truB to rnr (operon 4-F and operon
4-R). PCR products were run on a 0.7% agarose gel.
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Mutation of F. tularensis LVS FTL0552.
F. tularensis LVS FTL0552 knockouts were confirmed by PCR using primers
specific to FTL0552 and primers external to FTL0552 and the flanking region. The PCR
product from colonies obtained after one pass on media containing 5% sucrose revealed
two bands, consistent with the size predicted for the LVS parent strain FTL0552 gene
(2081bp) and the size predicted for the region of recombination (2349bp), indicating the
second recombinant event had not occurred and that the shuttle vector was still present
(Fig. 7A). After three passes on media containing 5% sucrose, PCR of the same colonies
revealed a single band at the size predicted for the recombinant region (2349bp),
indicating a second recombinant event had occurred and that the shuttle vector had been
lost. PCR with the primers specific for a region within the FTL0552 gene (FTL0552-F
and FTL0552-R, Table 1) revealed loss of the FTL0552 gene (Fig. 7B). To confirm the
recombination event occurred within the correct location within the chromosome, a third
PCR was performed using primers specific for the region flanking the area of
recombination (FTL0552+1100-F and FTL0552+1100-R, Table 1). The amplicon from
this PCR reaction was the size predicted for recombination within the chromosome (3158
bp) but differed from the F. tularensis LVS parent strain PCR product (2880 bp) (Fig.
7C). Primers specific for the kanR gene were also used in PCR reactions to confirm
incorporation of the kanR gene within F. tularensis LVS. Sequencing of the 3158 bp
PCR product amplified from F. tularensis LVS FTL0552::kanR revealed that nucleotides
26-645 of the FTL0552 gene (genome sequence 534341 to 534960) were deleted and
replaced with the kanR gene. RT-PCR using primers specific for FTL0552 was also
performed to confirm loss of transcription of FTL0552 gene in F. tularensis LVS
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FTL0552::kanR. As expected, FTL0552 was not amplified from RNA isolated from F.
tularensis LVS FTL0552::kanR but was amplified in the F. tularensis LVS parent strain
(Fig. 8).
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Figure 7. Confirmation of FTL0552 knockout. (A) PCR of colonies obtained after
one passage on agar with 5% sucrose. Primers are specific for the region of
recombination to confirm replacement of FTL0552 with the kanR gene. Lane 1;
exACTGene mid range DNA ladder, Lane 2; amplicon from LVS parent strain, Lanes 3
and 4; amplicons from potential FTL0552 mutants, Lanes 5 and 6; H2O controls. (B)
PCR of colonies after three passages on agar containing 5% sucrose. Primers are specific
for a region within the FTL0552 gene to confirm loss of FTL0552. Lane 1; exACTGene
mid range DNA ladder, Lane 2; amplicon from LVS parent strain, Lane 3; amplicon from
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Figure 7 (Continued).
potential FTL0552 mutant, Lane 4; H2O control. (C) PCR of colonies after three
passages on agar containing 5% sucrose. Primers are specific for the region flanking the
region of recombination to confirm incorporation within the chromosome. Lane 1;
Lambda BstE II DNA digest, Lane 2; amplicon from LVS parent strain, Lane 3; amplicon
from potential FTL0552 mutant, Lane 4; H2O control.
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Figure 8. Deletion of FTL0552 gene does not effect transcription of downstream
genes in the FTL0552 mutant. RT-PCR analysis of F. tularensis LVS FTL0552 and
adjacent genes was performed to confirm loss of FTL0552 transcription in the F.
tularensis LVS FTL0552 mutant and to determine the effects on downstream genes.
Lanes 1 and 2; amplicons using FTL0552 specific primers FTL0552-F and FTL0552-R,
lanes 3 and 4; amplicons using mutS (house keeping gene) specific primers mutS-F and
mutS-R, lanes 5 and 6; amplicons using lepB specific primers lepB-F and lepB-R, lanes 7
and 8; amplicons using rnr specific primers rnr-F and rnr-R. F. tularensis LVS RNA was
used for the reactions in lanes 1, 3, 5, 7 and 13. FTL0552 mutant RNA was used for the
reaction in lanes 2, 4, 6, 8 and 14. Lanes 9-12 are water controls and lanes 13 and 14 are
no reverse transcription (RT) controls. All PCR products are run on a 1.0% agarose gel.
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FTL0552 mutation appears to have little effect on downstream genes.
RT-PCR analysis, using overlapping primers was performed on RNA isolated
from F. tularensis LVS and F. tularensis LVS FTL0552 mutant using primers specific
for FTL0552, lepB and rnr (Table 1). The two genes, lepB and rnr, were selected to
determine the effects of knocking out FTL0552 on transcription of downstream genes
within the potential operon (Fig. 8). The results confirmed that FTL0552 was not
transcribed in the mutant strain, while the two downstream genes examined were
transcribed at levels similar to those seen in LVS (Fig. 8). Therefore, the phenotype seen
in the FTL0552 knockout mutant is not a result of polar effects but is directly attributed
to the mutation in FTL0552 and genes outside the putative operon that are regulated by
FTL0552.

FTL0552 mutant is unable to replicate in mouse macrophages.
A growth comparison between the LVS parental strain and the FTL0552 mutant
was performed to assess the effects of knocking out the FTL0552 gene on the bacteria’s
ability to grow in an acellular environment. Isolated colonies of F. tularensis LVS were
visible on supplemented GC agar plates in 24 hours. In contrast, isolated colonies from
the FTL0552 mutant were visible in 38-42 hours. Overnight broth cultures were
incubated at 37ºC with aeration for a period of 4 days and OD550 readings were measured
at several time points during the course of growth. Growth of the FTL0552 mutant
reached the same cell density as the parental strain of LVS, however, at a slightly slower
rate (Fig. 9). The mutant reached stationary phase of growth about 6-8 hrs after the
parental strain LVS.
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Figure 9. FTL0552 mutant exhibits a growth defect under acellular growth
conditions. The effect of FTL0552 gene deletion on growth under acellular conditions
was assessed by growing the FTL0552 mutant and wild type F. tularensis LVS in
Mueller Hinton broth. Aliquots were removed at the times indicated and the optical
density was measured at 550nm (OD550).
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The ability of the mutant to invade and replicate within mouse macrophages was
assessed using J774A.1 cells and mouse peritoneal macrophages. The cells were infected
with the parental strain LVS or FTL0552 mutant LVS at an MOI of 100 for J774A.1 cells
and an MOI of 50 for peritoneal cells for 2 hrs and 1.5 hrs, respectively. At the indicated
time points, viable counts were performed by lysing the cells and incubating serial
dilutions of the sample suspensions on GC agar plates. Over a period of 72 hrs, F.
tularensis LVS was able to invade and replicate within J774A.1 cells and bacterial
numbers increased approximately 50-fold (Fig. 10A). However, no viable bacteria were
recovered from J774A.1 cells infected with F. tularensis LVS FTL0552 mutant (Fig.
10A). Viable bacteria from PCs infected with the FTL0552 mutant were recovered but
the numbers were significantly less than the parental strain (Fig. 10B). Over a period of
48 hrs, the mutant bacterial numbers increased <20-fold, compared to the parental strain
bacterial numbers which increased >700-fold. An important factor contributing to the
virulence and dissemination of F. tularensis within a host is its ability to invade and
replicate within host macrophages. Mutation in FTL0552 appears to significantly alter
the bacterium’s ability to invade and replicate within mouse macrophage cells.
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Figure 10. Intracellular Survival Assay. (A) Macrophage invasion assay of FTL0552
mutant and F. tularensis LVS. Murine macrophage J774A.1 cells were infected with
FTL0552 mutant and F. tularensis LVS at an MOI of 100. Bacteria were allowed to
adhere to cells for two hours and then treated with 50 µg/ml gentamicin to kill the
extracellular bacteria. At the indicated time points, cells were lysed, serially diluted and
plated on GC agar plates to determine colony forming units. (B) Similar experiments
were conducted using thioglycolate elicited peritoneal macrophages from BALB/c mice
infected at an MOI of 50 for 1.5 hours. The results are expressed as CFU/ml and
represent means ± standard errors of the means of the colony forming unit counts (n = 3
per time point). *, P < 0.001; **, P < 0.05 (using the Student’s T-Test).
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FTL0552 mutant is deficient for invasion in MH-S alveolar macrophages.
The cell culture invasion assay with the J774 cells and the elicited peritoneal
macrophages has shown that the FTL0552 mutant is incapable of intracellular survival.
We investigated further if this phenotype is due to the inability of FTL0552 to invade the
macrophages. After 30 min of incubation with the labeled bacteria, we observed that
majority of the MH-S cells infected with GFP-LVS harbored 2-10 bacteria per cell. On
the contrary, cells infected with FTL0552 mutant contained very few bacteria (1-3
bacteria per cell) (Fig. 11). The results demonstrate that FTL0552 mutant is deficient for
invasion in the macrophages. Confocal microscopy confirmed that bacteria stained green
were localized inside the cells whereas, bacteria that took the counter stain and appeared
yellow when the images were merged together, were localized on the surface of the
macrophages (Fig. 11 Insets).
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LVS
FTL0552 mutant

Figure 11. Macrophage invasion assay using fluorescently labeled F. tularensis
FTL0552 mutant and GFP-LVS. Blue arrows indicate the bacteria stained green are
located inside the macrophages, where as, white arrows indicate bacteria stained yellow
are present on the surface of the cell. The macrophages were counterstained with PKH26
red fluorescence dye (Sigma St Louis, MO). Insets: Confocal images confirming the
localization of the bacteria within the cells.
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FTL0552 mutant is not affected by increasing levels of Magnesium, or acidic pH.
In Salmonella spp., the expression of several genes essential to survival in Mg2+limiting environments is governed by the PhoP/PhoQ system. Micromolar
concentrations of Mg2+ has been shown to activate transcription of at least 18 PhoP
activated genes, which are repressed in macromolar concentrations of Mg2+ (79). In
addition, other environmental conditions have been shown to modulate the expression of
other PhoP regulated genes essential to the survival of the bacteria in conditions such as
low pH or in the presence of hydrogen peroxide (79, 88). To assess whether FTL0552
responds to the same environmental stimuli as PhoP in other gram negative bacteria, I
compared the growth of F. tularensis LVS parent strain to the FTL0552 mutant in media
containing increasing concentrations of Mg2+ (Fig. 12). Surprisingly, the mutant grew
equally well in lower levels of Mg2+, compared to the parental strain. In addition, as the
Mg2+ concentration increased, growth of the parental strain decreased, whereas growth of
the FTL0552 mutant remained unaffected. The results suggest that FTL0552 is not
involved in Mg2+ transport. The growth of F. tularensis LVS parent strain and the
FTL0552 mutant in media of varying pH levels was then compared (Fig. 13). Again, the
FTL0552 mutant did not respond to acidic pH levels as expected for a PhoP mutant. The
FTL0552 mutant grew equally as well as, if not slightly better than, the parental strain in
an acidic environment. The results suggest that low pH alone is not an environmental
signal activating FTl0552 or governing the expression of FTL0552 regulated genes
essential to the survival of the bacteria in an acidic environment. Since PhoP has been
shown to play a role in hydrogen peroxide resistance in some bacteria, a comparison of
FTL0552 mutant sensitivity to hydrogen peroxide and F. tularensis LVS parental strain
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was performed (Fig. 14). There was no apparent difference observed between the
hydrogen peroxide sensitivity of the FTL0552 mutant as compared to the parental strain.
This alone does not indicate that FTL0552 does not play a role in hydrogen peroxide
resistance. Salmonella PhoP knockouts are susceptible to hydrogen peroxide killing
when grown in low Mg2+. Previous studies suggest that a functional phoP gene is
necessary for normal levels of rpoS during growth in low Mg2+. RpoS controls the
antioxidant enzyme exonuclease IIII, responsible for hydrogen peroxide resistance.
Inactivation of RpoS, renders Salmonella hypersensitive to hydrogen peroxide (88). The
rpoS gene is not found in F. tularensis LVS or the Schu S4 strain. Perhaps there could be
a similar connection between phoP and another rpoS-like gene in F. tularensis LVS.
However, FTL0552 does not appear to function or respond to the environmental signals
in the same manner as PhoP of other Gram negative bacteria. This suggests that,
although FTL0552 was identified by homology to a PhoP consensus amino acid
sequence, it does not display the same phenotypic properties of PhoP in other bacteria.
Recent studies identified and characterized the same gene (FTT1557c,
FNU0663.2) as an orphan response-regulator in F. tularensis subsp. novicida. The locus
was identified by homology to the Salmonella PmrA response-regulator. The Salmonella
TCS, PmrAB, regulates resistance to the antimicrobial peptide (AMP) polymyxin B. A
F. tularensis subsp. novicida pmrA mutant was 32-fold more susceptible to polymyxin B
than the parental strain (63). The F. tularensis LVS FTL0552 mutant was initially
selected on media containing 100µg/mL of polymyxin B, suggesting that FTL0552 is not
essential for resistance to polymyxin B in F. tularensis LVS. Polymyxin B MIC studies
revealed that there is no difference between the polymyxin B susceptibility of the
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FTL0552 mutant and the F. tularensis LVS parental strain. Both strains were resistant to
polymyxin B up to 1000µg/mL. Therefore, FTL0552 does not appear to display the same
phenotypic properties as PmrA of other Gram negative bacteria.
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Figure 12. F. tularensis LVS FTL0552 mutant response to increasing levels of
magnesium. LVS parent strain and FTL0552 mutant were grown in MH broth
containing increasing levels of magnesium. The optical density was measured to assess
growth.
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Figure 13. F. tularensis FTL0552 mutant response to acidic pH. LVS parent strain
and FTL0552 mutant were grown in MH broth of decreasing pH levels. The optical
density was measured to assess growth.
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Figure 14. F. tularensis LVS FTL0552 mutant response to hydrogen peroxide. LVS
parental strain and FLT0552 mutant bacterial cultures were either treated with hydrogen
peroxide or left untreated and incubated for 30 minutes. Serial dilutions of the samples at
each time point were plated on GC agar plates to determine viable colony forming units.
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FTL0552 mutant is attenuated for virulence in mice.
We screened the FTL0552 mutant in BALB/c and C57BL/6 mice to assess the
effect of the gene deletion on virulence. It was observed that all mice (n=10) of both
strains infected with 1x104 or 1x105 CFU of F. tularensis LVS succumbed by days 17-19
post infection. In contrast, all BALB/c and C57BL/6 mice survived similar doses of
FTL0552 mutant to at least day 21 post-infection (Fig. 15A and 15B). All mice that
survived the primary infective dose of 1x105 of FTL0552 mutant were challenged with
1x102 CFU of Schu S4 strain. It was observed that C57BL/6 mice had a significantly
extended MST of 9 days as compared to 6.5 days for the naive challenged mice. In the
BALB/c mice challenged with Schu S4, the first death was recorded at day 12 postchallenge and 30% (3/10) of the mice survived the challenge dose out to at least 45 days
post-challenge when the experiment was terminated (Fig. 15C). The other groups of
mice that survived initial infection with 1x104 CFU of FTL0552 were subsequently
boosted with 1x105 CFU of FTL0552 mutant and challenged with 1x102 CFU of Schu
S4. Although the MST for C57BL/6 mice treated in this manner was not altered
following challenge, 40% of the BALB/c mice survived until day 21 post-challenge and
the others had a significant delay in time to death (Fig. 15D). Thus, these results show
that the FTL0552 mutant is not only highly attenuated for virulence in mice, but also
retains its antigenic potential and provides partial protection against virulent Schu S4
challenge.
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Figure 15. FTL0552 mutant is attenuated for virulence in mice and provides partial
protection against lethal Schu S4 challenge. Survival of BALB/c (A) (n = 10) and
C57BL/6 (B) (n = 10) mice infected intranasally with 1 x 104 or 1x105 CFU of FTL0552
mutant or F. tularensis LVS.
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Figure 15 (Continued). (C). Mice surviving 1x105 CFU of FTL0552 mutant (n=10)
were challenged with 1x102 CFU of Schu S4. (D) Mice surviving 1x104 CFU of
FTL0552 mutant (n=10) were boosted with 1x105 CFU of FTL0552 mutant and
challenged 30 days later with 1x102 CFU of F. tularensis Schu S4 strain. Untreated mice
were kept as controls. Results are expressed as Kaplan-Meier curves and P values
determined using a Log-Rank test.
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FTL0552 mutant exhibits markedly reduced systemic dissemination and is cleared
rapidly.
We further investigated the kinetics of clearance of the FTL0552 mutant in mice.
C57BL/6 and BALB/c mice were infected i.n. with 5x103 CFU of either FTL0552 mutant
or LVS. The mice were sacrificed at the indicated times and bacterial numbers were
quantitated in the lung, liver and spleen. An identical pattern of bacterial kinetics was
observed in both BALB/c and C57BL/6 mice. At days 1, 3 and 5 post-infection, bacterial
numbers were significantly lower in the lungs of FTL0552 mutant-infected mice
compared to LVS infected mice, and at day 7 post-infection, bacteria were completely
eliminated from the lungs of FTL0552 mutant-infected mice (Fig. 16A). No significant
differences were observed in bacterial numbers in LVS or FTL0552 mutant infected mice
in the liver, at day 3 post-infection, but at subsequent time points no bacteria were
detected in FTL0552 mutant infected mice. Significantly lower numbers of FTL0552
mutant bacteria disseminated to the spleen as compared to the liver and no detectable
bacteria were seen day 5 and 7 post-infection (Fig. 16B). These results corroborate
attenuated virulence of FTL0552 mutant observed in mice and suggest that the
attenuation of FTL0552 mutant may be due to the rapid clearance and significantly
diminished dissemination.
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Figure 16. FTL0552 mutant is rapidly cleared by BALB/c and C57BL/6 mice. (A)
BALB/c and C57BL/6 mice were inoculated intranasally with 5 x 103 CFU of FTL0552
mutant or F. tularensis LVS. Four mice were killed at each indicated time point, and
homogenates of the lungs were plated for the determination of bacterial burden. (B)
Numbers of bacteria were quantified in the liver and spleen of the mice at day 3 postinfection. Results represent the means ± standard errors of CFU counts (n = 4 per time
point). **, P < 0.01; ***, P < 0.001 (using the nonparametric Mann-Whitney test).
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Infection with FTL0552 mutant induces less severe histological lesions.
Extensive damage to vital organs is believed to be the primary cause of death
from F. tularensis infection. We observed that the FTL0552 mutant is rapidly cleared;
we further evaluated tissue sections from LVS and FTL0552 mutant infected mice to
compare the degree of damage caused to the tissues by the two bacterial strains. Lesions
in the lungs, livers and spleens of FTL0552 mutant and LVS infected mice appeared as
early as 3 days post-infection and subsequently became more extensive by days 5 and 7
post-infection (Fig. 17A). Lesions in the lungs of LVS infected mice consisted mostly of
multifocal bronchopneumonia and extensive lymphocytic to neutrophilic peribronchial
and perivascular inflammation. However, these lesions were less severe and localized to
very discrete areas in the lungs of FTL0552 mutant infected mice (Fig. 17A). Livers
from LVS infected mice showed numerous multifocal neutrophilic to lymphocytic
granulomas. These granulomas became larger as the infection progressed. On the
contrary, few and very small granulomas were observed in the FTL0552 mutant infected
mice (Fig. 17B). Lesions in the spleen consisted of multifocal to coalescing areas of
neutrophilic infiltration in the red pulp, enlargement of the marginal zones, and extensive
proliferative responses in the germinal centers. However, the splenic tissue in FTL0552
mutant-infected mice appeared to be normal and no inflammatory changes were observed
(Fig. 17C). The results indicate that although the FTL0552 mutant is rapidly cleared
from the tissues, it still induces a degree of inflammation and development of mild
pathological lesions in the lungs and liver.
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Figure 17. Mice infected with FTL0552 mutant exhibit markedly less severe
histopathological lesions. Histopathological changes in the H&E stained sections of
lungs (A), liver (B), and spleen (C) of BALB/c and C57BL/6 mice (n=4) were evaluated
at day 5 after intranasal inoculation with 5x103 CFU of FTL0552 mutant or F. tularensis
LVS. Lung, liver, and spleen sections of sham-inoculated mice served as a control.
(Magnification x 40). Arrows indicate granulomas that were observed to be smaller in
mice infected with the FTL0552 mutant than those infected with LVS.
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Mice infected with FTL0552 mutant produce lower levels of inflammatory
cytokines.
Unregulated production of cytokines in response to F. tularensis infection has
been shown to be responsible for the severe histopathological lesions observed in the
lungs, livers and spleens of infected mice. We determined the levels of inflammatory
cytokines such as interferon-gamma (IFN-γ), tumor necrosis factor-alpha (TNF-α),
interleukin-6 (IL-6), monocyte chemoattractant protein (MCP-1) and interleukin 12 (IL12) in the lung homogenates of C57BL/6 and BALB/c mice infected either with LVS or
the FTL0552 mutant. LVS infected mice had significantly elevated levels of all
cytokines except IL-12 at days 5 and 7 post-infection (Fig. 18). The levels of IL-6 and
IFN-γ in FTL0552 mutant infected mice were below detection levels whereas elevated
levels of IL-12 were seen at day 7 post-infection. The results suggest that lowered
cytokine production results in less severe pathology in the lungs of FTL0552 mutant
infected mice.
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Figure 18. FTL0552 mutant exhibits lower levels of proinflammatory cytokines.
Following intranasal inoculation of BALB/c and C57BL/6 mice with 5x103 CFU of
FTL0552 mutant or F. tularensis LVS, lung homogenates were prepared, and levels of
proinflammatory cytokine levels were measured using Cytometric Bead Array (BD
Pharmingen, San Diego, CA). Results represent the means ± standard errors of the
means of the cytokine concentrations (n = 4 mice per time point). *, P < 0.05; **, P <
0.01; ***, P < 0.001 (by one-way ANOVA followed by Bonferroni's correction).
65

FTL0552 regulates genes essential for intracellular survival and virulence.
Gene microarray analysis revealed 148 genes regulated by FTL0552 (Table 2).
The genes are identified by a 4-fold or greater difference between F. tularensis LVS
parent strain and FTL0552 mutant. The majority (75%) of the genes regulated are down
regulated in the FTL0552 mutant, indicating they are FTL0552 activated genes. Among
the genes down regulated by the mutant, are the intracellular growth loci (iglA, iglB, iglC
and iglD). These genes are located in the FPI and have been shown to be essential for
intracellular survival (34, 54, 58, 65). Other down regulated genes include a macrophage
infectivity potentiator fragment, the gene encoding a type IV pili fiber building block
protein, ampC, fopA, and, interestingly, the superoxide dismutase gene, sodB. The type
IV pili fiber building block protein is involved in bacterial attachment and invasion of
host cells. Citrobacter freundii AmpC is a cytoplasmic membrane protein gene required
for induction of ß-lactamase and was recently identified as a permease required for
recycling of murein tripeptide and uptake of anhydro-muropeptides, which are produced
by turnover of the cell wall during logarithmic growth of E. coli K-12 (13). FopA is an
outer membrane protein specific to F. tularensis and is used as the target gene to rapidly
detect and distinguish F. tularensis from Francisella philomiragia and other bacteria by
LightCycler (LC) PCR (30) . The sodB gene in F. tularensis LVS encodes a functional
FeSOD protein essential for bacterial survival under conditions of oxidative stress. A
sodB mutant was attenuated for virulence in mice, indicating that FeSOD plays a role in
virulence of F. tularensis LVS (6). The genes that are up regulated in the FTL0552
mutant include several hypothetical proteins, and pseudogenes, two transposases, and,
interestingly, the gene encoding a type IV pili nucleotide-binding protein, pilT.
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Table 2. Genes regulated by FTL0552.

Fold Change

adj.P.Val

LVS loci

Gene

Product

rplC

50S ribosomal protein L3

Genes down regulated in FTL0552 mutant
-25.05928019

0.00233705

FTL_0236

-22.19311691

0.00597319

FTL_1789

gltA

citrate synthase

-19.35758199

0.00468233

FTL_0254

rpmD

50S ribosomal protein L30
elongation factor Tu (EFTu)

-18.02126118

0.00710756

FTL_1751

tufA

-17.77871998

0.00275065

FTL_0253

rpsE

-17.33021775

0.00816132

FTL_1452

rpmA

-17.19672181

0.01262576

FTL_1744

rpoB

-16.36824612

0.01503285

FTL_1158; FTL_0112

iglB

-16.04281684

0.01262576

FTL_0249

rpsN

-15.70008434

0.01625823

FTL_1553

sucC

-15.6848517

0.00496561

FTL_1138

acpP

30S ribosomal protein S5
50S ribosomal
protein L27
DNA-directed RNA
polymerase beta chain
intracellular growth locus,
subunit B
30S ribosomal protein S14
Succinyl-CoA synthetase
beta chain
acyl carrier protein
PEP-dependent sugar
phosphotransferase
system (PTS) family
protein

-15.5530817

0.02435709

FTL_1180

ptsN

-15.26151237

0.00597319

FTL_0250

rpsH

30S ribosomal protein S8

-15.17791631

0.01259213

FTL_0456

rpsU1

30S ribosomal protein S21

-15.02396164

0.00496561

FTL_0255

rplO

-14.7544992

0.00861015

FTL_0104

-14.14970215

0.02435709

FTL_1786

sdhA

50S ribosomal protein L15
hypothetical membrane
protein
succinate dehydrogenase,
catalytic and
NAD/flavoprotein subunit

-13.98444357

0.00387005

FTL_0234

fusA

elongation factor G (EF-G)

-13.95892199

0.01151088

FTL_0248

rplE

50S ribosomal protein L5

-13.82131408

0.01118009

FTL_1405

rpmI

50S ribosomal protein L35

-13.72452491

0.00928887

FTL_0251

rplF

50S ribosomal protein L6

-13.62834175

0.01259213

FTL_0247

rplX

-13.22678364

0.01831857

FTL_1159; FTL_0113

iglC

50S ribosomal protein L24
intracellular growth locus,
subunit C

-12.67540688

0.01860968

FTL_1404

rplT

50S ribosomal protein L20

-12.66500492

0.00721755

FTL_0252

rplR

50S ribosomal protein L18

-12.41193477

0.0176315

FTL_0457

cspC

cold shock protein

-12.34048842

0.01118009

FTL_0243

rplP

50S ribosomal protein L16

-11.89849425

0.00496561

FTL_0242

rpsC

-11.52757836

0.02475487

FTL_1790

ampG

-11.33508028

0.01262576

FTL_1328

fopA

30S ribosomal protein S3
major facilitator
superfamily (MFS)
tranport protein
outer membrane
associated protein

-11.17326652

0.01694981

FTL_1800

atpE

ATP synthase C chain

0.00861015

57 base overlap with
FTL_1024

overlaps
rpsF

overlaps 30S ribosomal
protein S6

-11.16020392
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succinate dehydrogenase
hydrophobic membrane
anchor protein

-10.76138971

0.01118009

FTL_1787

sdhD

-10.75579449

0.01262576

FTL_1746

rplJ

50S ribosomal protein L10

-10.53371666

0.01262576

FTL_1797

atpA

-10.43829441

0.02430586

FTL_1309

accD

ATP synthase alpha chain
Acetyl-CoA carboxylase
beta subunit
Glutaredoxin-related
protein

-10.11923752

0.01982448

FTL_1792

-10.11045205

0.03355773

FTL_1361

cspA

cold shock protein

-9.979771948

0.01625823

FTL_1479

pepA

cytosol aminopeptidase

-9.899502498

0.02915752

FTL_1748

rplK

-9.748119357

0.01262576

FTL_1736

trmD

50S ribosomal protein L11
tRNA (Guanine-N(1)-)methyltransferase

-9.676818132

0.01625823

FTL_1591

accC

Acetyl-CoA carboxylase,
biotin carboxylase subunit

-9.570639159

0.01831857

FTL_1791

sodB

superoxide dismutase [Fe]

-9.567494795

0.0130139

FTL_1026

rplI

-9.535239754

0.01118009

FTL_1097

-9.504769551

0.04137074

FTL_1843

gatC

-9.348565178

0.00948832

FTL_0421

lpnA

50S ribosomal protein L9
macrophage infectivity
potentiator, fragment
Glu-tRNAGln
amidotransferase C
subunit
conserved hypothetical
lipoprotein

-9.309757306

0.0111118

FTL_0246

rplN

50S ribosomal protein L14

-9.183991197

0.00948832

FTL_1735

rplS

-9.130656462

0.02475487

FTL_1745

rplL

-9.109343253

0.03973755

FTL_1749

nusG

-8.97743477

0.01625823

FTL_1442

fabI

50S ribosomal protein L19
50S ribosomal protein
L7/L12
transcription
antitermination protein
nusG
Enoyl-[acyl-carrierprotein] reductase
(NADH)

-8.931173932

0.01262576

FTL_1746

rplJ

-8.860087763

0.01625823

FTL_1802

50S ribosomal protein L10
hypothetical membrane
protein
dihydrolipoamide
succinyltransferase
component of 2oxoglutarate
dehydrogenase complex

-8.79275415

0.01625823

FTL_1783

sucB

-8.411502096

0.01118009

FTL_0259

rpsK

-8.2600092

0.01262576

FTL_1914

30S ribosomal protein S11
conserved membrane
protein

-8.120925628

0.0448537

FTL_1747

rplA

-7.98099707

0.01262576

FTL_1866

pcm

50S ribosomal protein L1
Protein-L-isoaspartate Omethyltransferase

-7.975037811

0.0130139

FTL_0224

rpsB

30S ribosomal protein S2

-7.953326091

0.00948832

FTL_1747

rplA

50S ribosomal protein L1

-7.906516041

0.01942492

FTL_1800

atpE

-7.901501728

0.02657508

FTL_1236

infA

ATP synthase C chain
translation initiation factor
IF
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-7.834059565

0.03192562

FTL_0449

hypothetical protein

-7.76975055

0.00948832

FTL_0240

rpsS

30S ribosomal protein S19

-7.723022596

0.02430586

FTL_1899

glnA

-7.605369341

0.01625823

FTL_1160; FTL_0114

iglD

glutamine synthetase
intracellular growth locus,
subunit D
UDP-3-O-[3hydroxymyristoyl] Nacetylglucosamine
deacetylase

-7.523342004

0.01625823

FTL_1906

lpxC

-7.463597743

0.01587326

FTL_1808

rbfA

-7.425803224

0.0130139

FTL_1744

rpoB

-7.324906566

0.02779293

FTL_0522

rpmB

-7.316623559

0.03355773

FTL_1794

atpC

-7.106487115

0.02126889

FTL_0457

cspC

-7.101383652

0.02915752

FTL_0225

tsf

-7.0326146

0.01880227

FTL_1161; FTL_0115
sdhB

Ribosome-binding factor A
DNA-directed RNA
polymerase beta chain
50S ribosomal protein L28
ATP synthase epsilon
chain
cold shock protein
protein chain elongation
factor EF-Ts
conserved hypothetical
protein
succinate dehydrogenase
iron-sulfur protein

-6.886330976

0.01474031

FTL_1785

-6.814183939

0.02915752

FTL_1908

ftsA

cell division protein FtsA

-6.788131408

0.01569351

FTL_0232

rpsL

-6.667272265

0.01262576

FTL_1392

deaD

-6.654382249

0.04137074

FTL_0552

-6.582903729

0.02587972

FTL_1866

pcm

-6.390042955

0.02435709

FTL_1157; FTL_0111

iglA

30S ribosomal protein S12
Cold-shock DEAD-box
protein A
Two-component response
regulator
Protein-L-isoaspartate Omethyltransferase
intracellular growth locus,
subunit A
conserved hypothetical
protein

-6.38412801

0.02475487

FTL_1364

-6.382618562

0.04208055

FTL_1538

rpsO

30S ribosomal protein S15

-6.356697689

0.03184661

FTL_1912

rpsA

30S ribosomal protein S1

-6.315994198

0.01860968

FTL_0248

rplE

-6.252961264

0.03500214

FTL_1400

-6.233222608

0.01587326

FTL_1809

infB

50S ribosomal protein L5
conserved hypothetical
protein
translation initiation factor
IF-2

-6.178737226

0.01810894

FTL_0262

rplQ

50S ribosomal protein L17

-6.154009595

0.01625823

FTL_0175

rpmH

50S ribosomal protein L34

-6.122084398

0.02915752

FTL_0166

usp

-5.973209935

0.01587326

FTL_1461

deoD

universal stress protein
purine nucleoside
phosphorylase

-5.957196557

0.01587326

FTL_1799

atpF

-5.94144208

0.04208055

FTL_1811

69

ATP synthase B chain
conserved hypothetical
protein
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-5.90717608

0.03500214

FTL_1785

sdhB

succinate dehydrogenase
iron-sulfur protein
signal recognition particle
protein, Ffh

-5.836772303

0.02330711

FTL_1239

ffh

-5.818402609

0.02891333

FTL_0252

rplR

-5.71724013

0.03500214

FTL_1788

sdhC

-5.620673623

0.02915752

FTL_1737

rimM

-5.612959849

0.03500214

FTL_1137

fabF

-5.578672881

0.02700348

FTL_0392

-5.496727729

0.01729659

FTL_1789

gltA

citrate synthase

-5.456963006

0.02246866

FTL_1795

atpD

ATP synthase beta chain

-5.384322677

0.0448537

FTL_0070

rpsT

30S ribosomal protein S20

-5.320586462

0.02435709

FTL_0260

rpsD

30S ribosomal protein S4

-5.268390745

0.02988088

FTL_1453

rplU

50S ribosomal protein L21

-5.235104687

0.02587972

FTL_1892; FTL_1317

50S ribosomal protein L18
succinate dehydrogenase,
cytochrome b556
16S rRNA processing
protein rimM
3-oxoacyl-[acyl-carrierprotein] synthase II
Type IV pili fiber building
block protein

-5.192961998

0.02444671

FTL_1309

accD

hypothetical protein
Acetyl-CoA carboxylase
beta subunit

-5.178980027

0.03184661

FTL_1738

rpsP

30S ribosomal protein S16

-4.941337444

0.04390467

FTL_1504

katG

Peroxidase/catalase

-4.761407043

0.03905373

FTL_1143

rmpF

-4.507271922

0.03754453

FTL_1780

tpiA

50S ribosomal protein L32
triosephosphate
isomerase

glpe

thiosulfate
sulfurtransferase

Genes down regulated in FTL0552 mutant
4.657900941

0.0476291

FTL_0010

4.758190213

0.04862308

FTL_0864

SIS domain protein

4.903062161

0.04424048

FTL_0035

hypothetical protein

5.887486797

0.02330711

FTL_1373

hypothetical protein

0.03500214

intergenic between
FTL_1368 and FTL_1369

hypothetical protein

0.048071

intergenic between
FTL_0408 and FTL_0409

hypothetical protein

6.086182237

0.0448537

intergenic between
FTL_1645 and FTL_1646

6.152287936

0.02371267

intergenic between
FTL_1953 and FTL_1954

6.288269169

0.01915536

FTL_0568

isftu2

6.375452213

0.01503285

FTL_0496

thrB

6.819971411

0.02007481

FTL_0474

lolC

5.94921963
6.046543067
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conserved hypothetical
membrane protein
Transposase
homoserine kinase
(pseudogene)
lipoprotein releasing
system, subunit
C,putative membrane
protein
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0.01694981

FTL_0495

thrA

bifunctional
aspartokinase/homoserine
dehydrogenase I
(pseudogene)

7.408171347

0.01997309

intergenic between
FTL_1589 and FTL_1590

msc

mechanosensitive ion
channel protein

7.613734457

0.040795

FTL_1124

7.906864993

0.02297458

FTL_1944; FTL_1925

isftu1

8.066832218

0.03184661

19 base overlap with
FTL_1648

oppF

8.103479133

0.04138666

FTL_0562

Transposase
oligopeptide transporter,
subunit F, ABC transporter,
ATP-binding protein
conserved hypothetical
protein, pseudogene

8.241788902

0.02430586

FTL_1280

D-Beta-hydroxybutyrate
dehydrogenase,psuedogene

8.871987933

0.03965435

FTL_0775

9.181028537

0.00597319

intergenic between
FTL_1493 and FTL_1494

9.303168779

0.03564467

FTL_0446

9.721982075

0.03564467

FTL_1092

9.947699861

0.02475487

intergenic between
FTL_1336 and FTL_1337

9.983033158

0.02700348

FTL_0323

10.09337723

0.0146488

FTL_1281

10.10298529

0.02050863

FTL_0501

10.17116049

0.01625823

FTL_0446

10.39217736

0.01860968

10.74624435

7.238472409

hypothetical protein

hsdR1

Type I restriction enzyme
subunit R, pseudogene
hypothetical protein

betT

hypothetical protein
Betaine/carnitine/choline
transporter (BCCT) family
protein, pseudogene
amino acid permease
family protein, pseudogene
Smf protein DNA
processing chain A,
pseudogene

speA

D-Beta-hydroxybutyrate
dehydrogenase,psuedogene
putative arginine
decarboxylase

FTL_1770

pilT

hypothetical protein
Type IV pili nucleotidebinding protein

0.03973755

FTL_0022

gabD1

Succinate-semialdehyde
dehydrogenase, fragment

FTL_0702

hypothetical protein
deoxyribodipyrimidine
photolyase

12.4857256

0.01915536

13.11213182

0.02788963

13.13737321

0.03099376

FTL_1767

14.11177762

0.01262576

FTL_1944; FTL_1925

15.11674799

0.03500214

16.50777825

0.03973755

67 base overlap with
FTL_0634

17.7128157

0.04949982

FTL_1844

isftu1

Transposase
hypothetical protein

naoX

NADH oxidase
Secretion protein
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SDS-PAGE analysis reveals a soluble protein deleted from the FTL0552 mutant.
In addition to gene microarray analysis, I used SDS-PAGE to compare protein
expression of F. tularensis LVS parent strain and FTL0552 mutant. Bacterial lysate and
supernatant samples were run on two SDS-PAGE gels and stained with Coomassie
Brilliant Blue and Silver Stain. There was no observable difference between the two
strain’s lysate or supernatant samples on the Coomassie Blue stained gel. However, the
more sensitive Silver Stain revealed a protein band, migrating between 25-30 kDa, from
the supernatant fraction of the F. tularensis LVS parental strain that is absent in the
FTL0552 mutant sample (Fig. 19). Lowered production of a soluble protein in the
FTL0552 mutant is not surprising given the number of genes identified as being regulated
by FTL0552. Survival of F. tularensis LVS within host cells depends on the bacterium’s
ability to have a mechanism which protects the bacteria from degradation by the host cell,
allows escape from the phagosome, replication within the cytoplasm and signals the host
cell to undergo apoptosis in order for the bacteria to be released and invade new cells.
While several genes have been identified as being essential to the intracellular survival of
F. tularensis, the mechanism has yet to be characterized. Further analysis is required to
identify the secreted proteins and their role in the interaction with the host cell.
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Figure 19. Silver Stain of F. tularensis LVS and FTL0552 mutant bacterial
proteins. Lane 1 Mult Mark protein ladder; Lane 2; media alone, Lanes 3 and 5; LVS
wild type cleared lysate at 10µg and 20µg, Lanes 4 and 6; FTL0552 mutant cleared lysate
at 10µg and 20µg, Lane 7; media alone, Lane 8; LVS wild type supernatant at 20µg,
Lane 9; FTL0552 supernatant at 20µg.
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Discussion

It was the goal of this project to identify genes encoding potential two-component
regulatory systems in the F. tularensis that may be involved in regulation of virulence
factor genes. In order to identify potential response-regulator genes that activate genes
necessary for bacterial virulence, we searched the F. tularensis LVS genome using a
consensus amino acid sequence derived from the phoP response-regulator genes from
other Gram-negative bacteria. One locus, FTL0552, was identified by the similarity of its
protein product to the PhoP response-regulator consensus sequence. The FTL0552 locus
is 687 nucleotides in length and was annotated in the genome sequence as a
transcriptional response-regulator. The corresponding locus in F. tularensis Schu S4
(FTT1557c) is highly conserved.

In this report we describe the construction of a deletion mutant for FTL0552 in F.
tularensis LVS. The FTL0552 gene was interrupted with a kanR gene, replacing
nucleotides 26-645. A knockout mutant in the response-regulator gene (FTL0552) was
constructed by combining PCR generated products delivered by conjugation, with
subsequent recombination into the bacterial chromosome by allelic replacement. F.
tularensis LVS mutant deleted for FTL0552 was shown to be defective for survival in
both mouse J774A.1 cells and peritoneal macrophages. This mutant was completely
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attenuated in both BALB/c and C57BL/6 mice at doses up to 1 X 105 CFU/ mouse.
Challenge studies of mice surviving infection with the FTL0552 mutant using the virulent
Schu S4 strain suggest that some level of protective immunity is afforded to these mice.
Furthermore, mice infected with the FTL0552 mutant exhibited reduced levels of proinflammatory cytokine production, and reduced evidence of histopathology in affected
tissues, and correspondingly, reduced systemic infection and rapid clearance of the
bacterium. Our results support a major role for the FTL0552 gene product in controlling
expression of virulence genes in F. tularensis.

Despite identification of the genomic locus (FTL0552) encoding this gene by
homology with a PhoP consensus sequence from other bacteria, it does not appear to
function as a PhoP homologue. While the poor intramacrophage survival and reduced
virulence in mice are consistent with phoP mutants described in other bacteria (38), the
growth rate was not significantly altered at low Mg2+ concentrations. Low Mg2+
environments have been reported to result in slower growth for Salmonella phoP
mutants, suggesting PhoP plays a role in regulating genes associated with Mg2+ transport,
as well as increased susceptibility to hydrogen peroxide, and acidic pH (38, 88). The F.
tularensis FTL0552 mutant was not observed to exhibit either property. Additionally,
the absence of an adjacent gene on the F. tularensis genome sequence that is homologous
to the sensor histidine kinase, phoQ, differs from the gene arrangement in other bacteria
where phoP/phoQ forms a two-gene operon (38). However, it is certainly possible that
FTL0552 could form a two-component regulatory system with the product of an
unknown gene located within another region of the F. tularensis chromosome. At this
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point, it is unclear if FTL0552 encodes a response-regulator that is part of a twocomponent system. Two loci sharing homology to PhoQ have been identified (FTL1878
and FTL1762) and are being examined to determine if either gene is the cognate sensor
histidine kinase functioning to activate FTL0552.

FTL0552 protein is highly conserved among various Francisella strains including
Francisella tularensis subsp. holarctica OSU18 (NC008369), Francisella tularensis
subsp. tularensis FSC 198 (NC008245), and Francisella tularensis subsp. tularensis
Schu S4 (NC006570). When the deduced amino acid sequence derived from FTL0552
was used in a BLAST search against all peptide and translated sequences in GenBank,
the best hits were known or putative response-regulators. Included in these hits was
PmrA from Pseudomonas aeruginosa, the response-regulator part of the two-component
regulatory system PmrA-PmrB. PmrA is activated through PmrB and responds to
extracellular iron and mild acid pH and confers resistance to polymyxin B and other
antimicrobial peptides in Salmonella (50, 63, 92). Functional PmrA is required to allow
Salmonella to adapt to the toxic effects of high iron environments (92). Since PmrA
mutants in other bacteria are typically more susceptible to polymyxin B, we might expect
the FTL0552 mutant to also be more susceptible to polymyxin B (92). However, the
initial selection of our FTL0552 mutant was performed in the presence of 100 µg/ml of
polymyxin B suggesting that FTL0552 is not necessary to confer resistance to polymyxin
B and does not function in the same manner as PmrA in other bacteria. The FTL0552
mutant was resistant to polymyxin B up to a concentration of 1000 µg/ml. Thus, the
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stimulus that is responsible for activating genes that are regulated by FTL0552 remains
uncharacterized.

The PmrA-PmrB system in Salmonella controls the transcription of several genes
necessary for polymyxin B resistance and mediates the modification of LPS when
induced by high iron or promoted by growth in low magnesium (39, 40, 50). However,
PmrA-activated genes stimulated by growth in low magnesium requires another twocomponent system, PhoP-PhoQ (50). Previous studies defined the genetic basis for the
interaction between the PhoP-PhoQ and PmrA-PmrB systems that regulates expression of
antimicrobial resistance determinants in response to two different environmental
conditions (50). In the presence of low magnesium, PhoP mediates transcription of the
pmrD gene that mediates the transcriptional induction of PmrA-activated genes (50). In
the presence of excess iron, transcriptional activation of PmrA-activated genes is
independent of PmrD, which controls the activity of the PmrA-PmrB system at a posttranscriptional level (50). A model for activation of the PmrA-PmrB system by the
PhoP-PhoQ system is described by Gunn et al., 1998 (Fig. 20) (40, 50). PhoQ serves as a
magnesium sensor that modulates PhoP to activate the pmrD gene. The interaction
between PhoP-PhoQ and PmrA-PmrB in Salmonella is a novel type of interaction
between a pair of two-component systems, affording the bacteria physiological plasticity
in response to a broad spectrum of environmental conditions (50). The ability of the
FTL0552 mutant to retain polymyxin B resistance indicates that the gene does not
function like PmrA of other bacteria. However, the bacterium was exposed to polymyxin
B under normal growth conditions. Perhaps exposure to a high iron or low magnesium
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environment would render the FTL0552 mutant sensitive to polymyxin B, due to the loss
of activation of genes involved in LPS modification and polymyxin B resistance.
However, a mutant in this gene in F. tularensis subsp. novicida (FNU663.2) was found to
be sensitive to antimicrobial killing by polymyxin B but apparently not through the
typical mechanism of LPS modification (Mohapatra, Soni et al. 2007). This suggests that
LVS FTL0552 and pmrA of F. tularensis subsp. novicida exhibit unique phenotypic
properties and the stimuli responsible for activating FTL0552 remains uncharacterized.
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Figure 20. Model for the activation of the PmrA–PmrB two-component system by
the PhoP–PhoQ two-component system. Transcription of PmrA-activated genes can be
induced by growth in high iron independently of the PhoP–PhoQ two-component
system (right) or by growth in low magnesium in a PhoP–PhoQ-dependent manner (left).
During growth in low magnesium, the PhoP–PhoQ system promotes expression of the
pmrD gene. The PmrD protein controls the activity of the PmrA–PmrB system at a posttranscriptional level. The seven-gene pbgP/E operon has also been designated the pmrF
locus (adapted from Linda F.F. Kox, Marc M.S.M. Wösten, and Eduardo A. Groisman,
2000).
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The gene encoding the FTL0552 response-regulator appears to be present as the
first gene of a cluster of five genes. The intergenic space between these genes is either
extremely short or absent. Some of the genes overlap with the putative start codon for
truB located inside the reading frame for rnc and the start codon for rnr is inside the
reading frame for truB. Thus, it is unlikely that promoter and transcription termination
sequences for each or any of these five genes are located inside this putative operon.
RT-PCR analysis revealed that FTL0552 is transcribed as a five-gene operon. The other
genes included in this putative operon include signal peptidase I (lepB), ribonucleases
(rnc, and rnr) and tRNA pseudouridine synthetase B (truB). The five-gene arrangement
is conserved in Francisella tularensis subsp. holarctica OSU18 (NC008369), Francisella
tularensis subsp. tularensis FSC 198 (NC008245), and Francisella tularensis subsp.
tularensis Schu S4 (NC006570). While it may be possible that some of these genes (the
ribonucleases) are involved in some aspect of gene regulation, it appears that they encode
proteins with diverse functions. This unusual cluster of genes is suggestive of some type
of recombination event early in the evolution of Francisella spp.. Interestingly, with the
exception of FTL0552, the gene arrangement is conserved in Legionella spp..

A hallmark of F. tularensis infection is the bacterium’s ability to invade and
replicate within host macrophages. Once adapted to the host target cells, the bacterium is
able to vigorously multiply before the host can offer a protective immune response, and
spread to various organs such as the liver and spleen (32, 34). The host-derived response
to the rapidly multiplying bacteria, results in severe organ damage and is primarily
responsible for the high mortality associated with F. tularensis LVS in mice and F.
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tularensis tularensis (Type A) in humans (34). Mutations in genes encoding bacterial
proteins associated with intracellular growth have been shown to result in attenuation of
F. tularensis LVS (32, 34). Our studies indicate that the FTL0552 mutant is defective in
intracellular replication in macrophages. These findings are corroborated by the studies
performed in the mouse model. The FTL0552 mutant is completely avirulent in the
mouse model. When boosted, 40% of the BALB/c mice that had been infected with the
FTL0552 mutant survived subsequent challenge with the highly virulent Schu S4 strain.
Therefore, the FTL0552 mutant is not only highly attenuated in mice, but also retains its
antigenic potential and provides partial protection against virulent Schu S4 challenge.

The mutant exhibited reduced dissemination and decreased ability to induce
histopathology in the target organ tissues. Mice infected with the FTL0552 mutant were
able to clear the bacteria much more efficiently than mice infected with the parental LVS
strain. Significantly lower numbers of bacteria disseminated to the spleen and were
completely cleared by day 5. After intranasal infection with the mutant strain, the mice
were able to completely clear the bacteria from the lung by day 7. The efficiency of
clearance correlated with the reduced histopathology evident in the lung, liver and spleen
of FTL0552 mutant infected mice, with the spleen appearing normal and no
inflammatory changes observed. Although some lesions and inflammation were
observed in the liver and lung, there were very few, small lesions in these organs which
was dramatically different from the parental LVS strain infected mice.
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The mutant caused a reduced level of inflammatory cytokine production yet
afforded partial protection to Schu S4 challenge. The low levels of acute phase
inflammatory cytokines from the FTL0552 infected lungs correlated with the low level of
organ damage seen. The increase in IL-12 indicates that a protective immune response
was induced and is a very promising finding for developing a vaccine that is protective
against F. tularensis. Of note, treatment of mice with IL-12 has previously been shown
to induce significant protection against the lethal respiratory tularemia (20).

DNA microarray analysis identified 148 genes regulated by FTL0552 in F.
tularensis LVS. Of the genes identified, 75% were activated by FTL0552 and 1/3 of the
genes repressed by FTL0552 were hypothetical proteins. The genes that are up regulated
by the FTL0552 mutant include pseudogenes, two transposases, and, interestingly, the
gene encoding a type IV pili nucleotide-binding protein, pilT. Among the 113 genes
activated by FTL0552 are the intracellular growth locus genes found within the FPI, iglA,
iglB, iglC and iglD. These genes have been shown to be essential for infection and
survival within macrophages (34, 54, 58, 65). In addition, FTL0552 was shown to
activate genes encoding a macrophage infectivity potentiator, type IV pili fiber building
block protein, the transport protein (ampG), the outer membrane protein (fopA), and the
sodB gene. The type IV pili fiber building block protein is involved in the bacterium’s
ability to attach and invade host cells and the loss of expression of this gene is likely to
result in a defect in the bacteria’s ability to infect macrophages, as seen in the FTL0552
mutant. The sodB gene has been shown to play a role in virulence of F. tularensis LVS
(6). F. tularensis LVS SodB mutants were attenuated for virulence in mice.
82

The loss of expression of these genes is likely to play a role in the impaired intracellular
survival and the attenuated virulence in mice observed by the FTL0552 mutant.

The presence of orphaned members of TCS in Francisella tularensis represents a
unique phenomenon of virulence regulation to allow for the survival and persistence of
this bacterium within a variety of environments. The lack of the typical TCS
arrangement could be the result of evolutionary changes and the presence of five
insertion elements scattered throughout the genome (58). The genetic basis of F.
tularensis pathogenesis is poorly understood and only beginning to be studied. The
recent advancements in genetic tools to manipulate F. tularensis has offered the
Francisella community opportunities for making specific mutations and studying the
bacteria at the genetic level that has, until now, hindered the progression of research in
this area, particularly for type A and type B strains.

In summary, we have described a strain of F. tularensis LVS that is deleted for
FTL0552 encoding a putative response-regulator. This mutant is defective for replication
in macrophages and is avirulent in the mouse model.

Although the phenotypic

properties observed in the FTL0552 mutant are inconsistent with PhoP of other bacteria,
it clearly plays a role in regulation of virulence genes in F. tularensis LVS. Perhaps, as
an orphan response-regulator, FTL0552 works in trans with other regulatory proteins to
exert its effect. Identification of a sensor histidine kinase responsible for the activation of
FTL0552 could provide insight into the environmental signaling cues that modulate the
activity of this gene. Two loci sharing homology with PhoQ were identified by searching
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the database with a derived PhoQ consensus sequence from other gram negative bacteria
(FTL1762 and FTL1878). The genes are identified as a sensor histidine kinase (qseA)
and a two-component sensor protein (kdpD). QseA is the quorum sensing Escherichia
coli regulator A and KdpD is the sensor kinase in the two-component regulatory system,
KdpD-KdpE, responsible for regulating intracellular K+ in E. coli. Although most twocomponent sensor kinases are specific for activation of their cognate response-regulator,
it is possible evolution has forced some bacteria to adapt by programming sensor kinases
to respond to more than one environmental cue and act on more than one responseregulator to exert a coordinated response for survival. This could explain the
inconsistencies with the phenotypic properties of FTL0552 and the lack of a typical
cognate sensor kinase. Identifying the environmental cues leading to activation of
FTL0552 will provide insight into the protein interaction leading to FTL0552 activation
and modulation of virulence genes.

Currently, the data presented supports the role of FTL0552 in regulation of
virulence in F. tularensis LVS and provides an opportunity for investigation of the effects
of an FTT1557c mutant in F. tularensis subsp. tularensis for evaluation as a possible
vaccine candidate. Such a mutant may form the basis of a defined live attenuated
vaccine that affords protection in humans against more virulent type A strains.
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